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Accurate chromosome segregation during cell division is essential for the maintenance
of a cell’s genomic stability. The molecular surveillance mechanism called the spindle
assembly checkpoint (SAC) inhibits chromosome segregation before all chromosomes
are correctly attached (bi-oriented) on the microtubule spindle to prevent segregation
errors that may lead to chromosomal instability and cell death. In this thesis, I have
developed and used tools to examine the roles of different checkpoint proteins in the
mechanism of SAC signaling. In the first part of the thesis, I manipulate the localization
of the checkpoint protein Mad1 and show that its constitutive presence at the
kinetochore is sufficient to induce checkpoint arrest. Being able to uncouple checkpoint
signaling from chromosome biorientation, I use the system as a tool to examine the
roles of checkpoint kinases in SAC signaling downstream of kinetochore recruitment of
Mad1. I show that the kinases Mps1 and Aurora B are necessary for the maintenance of
checkpoint arrest, independently of their other “upstream” checkpoint functions. I also
show that localization of Mad1 at other chromosomal locations is not per se sufficient to
induce checkpoint arrest. In the second part of the thesis, I collaborate in the
development of a tool for the study of the protein dynein, a microtubule-associated
motor with mitotic regulatory roles in spindle assembly, kinetochore-microtubule

interactions and SAC silencing, as well as a variety of cargo-translocation roles in
interphase. I examine the effects of the small molecule “ciliobrevin” in mitotic cells and
help validate it as the first specific dynein inhibitor. Although I determine that its effects
on the microtubule spindle will preclude its use in checkpoint silencing studies,
ciliobrevin will still be a powerful tool for other biochemical, structural and cellular
investigations of dynein function.

“Le rêve de toute cellule: devenir deux cellules.”
François Jacob
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Chapter 1: Introduction to the
Spindle Assembly Checkpoint
Overview of the cell cycle and mitosis
Mitosis, the biological process by which a cell divides into two “daughter” cells, is
essential for the maintenance of organisms’ lives. In multicellular organisms, mitosis is
necessary for growth, development, organ homeostasis and wound-healing. The
maintenance of genetic fidelity in (most) somatic cells is essential for the well-being of
the organism, given that genetic instability can give rise to a variety of diseases and
death (Pfau and Amon, 2012; Holland and Cleveland, 2012).
Before being able to divide, cells must pass through an orderly, unidirectional and
irreversible series of phases of the cell cycle. Progression through the cell cycle is driven
by complex, interlocking molecular circuits, powered by the activity of conserved cyclindependent kinases (CDKs; Morgan, 2008a, b). The first phase of a newly formed cell is
G1 (gap) phase, in which the cell can grow and carry out its functions. Most somatic cells
exist in this phase or a similar, quiescent phase called G0 (for cells that do not divide).
For a cell to be able to divide into two genetically identical daughter cells, i.e. to
undergo mitosis, it must first duplicate its genetic material (DNA, wrapped around
nucleosomes to form chromosomes). Upon certain proliferative stimuli, cells progress
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from G1 to S (DNA synthesis) phase, in which chromosomes and (other cellular
structures such as the centrosomes) are replicated. At this point, the replicated
chromosome is held together (i.e., its two sister chromatids are under cohesion).
Further growth and housekeeping processes are carried out during the ensuing phase,
G2, before the cell is ready to start mitosis (M phase). During the prophase stage of
mitosis, the chromosomes condense, the nuclear envelope breaks down and the
microtubule cytoskeleton is rearranged into a bipolar structure called the spindle.
Chromosomes are then bound by microtubule polymer bundles (kinetochore fibers) at a
specialized proteinaceous structure called the kinetochore and are then aligned in the
middle of the cell at the metaphase plate. When kinetochores of both sister chromatids
of all kinetochores are bioriented, i.e. when each sister kinetochore of the pair is
attached to microtubules emanating from a different spindle pole, the cell breaks the
cohesion between the chromosomes to allow metaphase to progress into anaphase
(Fig. 1.1). During anaphase, the separated chromatids are physically transported to
opposite sides of the cytoplasm (driven by kinetochore fiber depolymerization), after
which nuclear envelopes re-form (telophase) and the membrane in the middle of the
cell ingresses into a furrow that will eventually completely separate both sides of the
cytoplasm (cytokinesis), giving rise to two independent cells. These newly formed cells
then enter G1 phase if they are to remain proliferative, or G0 phase if they are to
become quiescent.

2

Figure 1.1 Types of chromosome-microtubule attachment and orientation on the
spindle. Non-bioriented chromosomes can be: (a) unattached, (b) monopolarly attached
(only one kinetochore of the pair contacts microtubules), (c) syntelically attached (both
kinetochores are attached by microtubules emanating from a single pole), (d)
merotelically attached (both kinetochores are attached, but one of them contacts
microtubules emanating from two different poles), or (e) bipolarly attached (both
kinetochores are attached, each to microtubules emanating from a single and distinct
pole). Biorientation only occurs when the chromosome is bipolarly attached.
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Molecular checkpoints ensure the fidelity of cell cycle progression
Errors in the sequence or timing of mitotic events can lead to genetic instability and cell
death. Because of the importance of fidelity of cell division in the maintenance of
genomic stability, cell cycle events must be tightly coordinated. Coordination of the cell
cycle of eukaryotic cells is achieved by “checkpoints”: molecular surveillance
mechanisms (dependent relationships) that do not allow late events to occur before the
successful completion of early ones (Hartwell and Weinert, 1989). A number of
checkpoints exist at different stages of the cell cycle (G1/S, S, G2/M, etc).
For the work described here, I have focused on the spindle assembly checkpoint
(SAC): the mechanism that arrests mitotic cells in metaphase, preventing the
progression into anaphase until all chromosomes are bioriented and providing time for
orientation errors to be corrected (Musacchio and Salmon, 2007). Because
depolymerization of the kinetochore-attached microtubule fibers powers chromatid
translocation during anaphase, proper kinetochore-microtubule interactions are
essential to ensure faithful segregation (Mitchison et al., 1986; Gorbsky et al., 1987;
Koshland et al., 1988). By only allowing chromosomal segregation in cells with a full
complement of correctly attached (bioriented) chromosomes, the spindle assembly
checkpoint prevents mis-segregation events that would lead to genetic aberrations,
instability and death in the daughter cells.

4

The Spindle Assembly Checkpoint

A short history of spindle assembly checkpoint origins
The concept of a cell cycle checkpoint was originally formally proposed by Hartwell and
Weinert in 1989 (Hartwell and Weinert, 1989). They recognized that the order of events
of the cell cycle is regulated in wild type cells such that late events do not occur until the
successful completion of previous events has been finished and that these pathways of
dependent relationships are key for the fidelity of cell division. In their seminal article,
they review existing data and propose that a variety of such checkpoints are true
feedback control mechanisms, as opposed to mere “substrate-product” intrinsic
structural requirements (Hartwell and Weinert, 1989). The initial criterion for the
identification of these pathways as control mechanisms was the existence of “relief of
dependence conditions” such as mutations or chemical inhibition that allowed a late
event to occur in the absence of the completion of an earlier event. Hartwell and
Weinert argued that these relief-of-dependence observations were very unlikely to arise
from structural changes in the proteins and thus established the concept of checkpoint
control mechanisms.
In fact, Hartwell and Weinert themselves established the role of the protein
RAD9 in the DNA damage checkpoint of budding yeast (Weinert and Hartwell, 1988).
They showed that, at the restrictive temperature, rad9 temperature-sensitive mutants
in which DNA damage has been induced by x-ray irradiation fail to arrest in G2 and
instead proceed into cell division regardless of the DNA damage present (which, on the
5

contrary, causes G2 arrest in wild type cells or in rad9 mutants at the permissive
temperatures). Furthermore, irradiated rad9 cells can efficiently repair damaged DNA if
cells are blocked in G2 is using microtubule poisons. Thus, they established that RAD9
forms part of a feedback mechanism (a checkpoint) that delays entry into mitosis in the
presence of DNA damage.
The initial discovery of the spindle assembly checkpoint genes came a couple of
years later from the laboratories of Andrew Hoyt and Andrew Murray (Hoyt et al., 1991;
Li and Murray, 1991). They hypothesized that the mitotic arrest seen when microtubules
are disrupted is also due to a checkpoint mechanism. To test this, Rong Li and Andrew
Murray devised a screen that would differentiate “structural” mutants (e.g. with a
deficiency in tubulin polymerization) from mutants arising from a true checkpoint
mechanism (Li and Murray, 1991). They incubated the mutagenized budding yeast cells
in sub-lethal concentrations of the microtubule depolymerizing agent benomyl. Under
these conditions, three distinct responses would be seen from the different populations.
In wild type cells, completion of mitosis would be delayed (not blocked) until a proper
spindle could be assembled and proper biorientation, achieved. Structural mutants
would be unable to assemble a spindle and progress through mitosis at all. On the other
hand, mutants in the putative feedback checkpoint mechanism would fail to delay
mitosis in response to the improperly assembled spindle and would progress through
mitosis un-delayed, which would lead to chromosome mis-segregation and cell death.
Moreover, this benomyl hypersensitivity should be rescued by a delay in S-phase, which
would allow a longer time for the yeast spindle to form. From this carefully designed
6

screen, Li and Murray were able to isolate three checkpoint mutants: Mad1, Mad2 and
Mad3 (Li and Murray, 1991).
Similarly, Andrew Hoyt and Tibor Roberts carried out an independent screen to
identify relief-of-dependence mutants that would fail to arrest in mitosis with a
disrupted spindle (Hoyt et al., 1991). They initially identified mutants that failed to
efficiently recover from a transient, complete block of microtubule polymerization (by
exposure to high concentrations of benomyl), presumably due to their inability to pause
the cell cycle while the spindle recovered. Under closer inspection, a number of these
mutants also underwent several rounds of budding in the presence of benomyl.
Moreover, this new group of mutants was also hypersensitive to sub-lethal
concentrations of benomyl. This screen thus identified the second group of checkpoint
genes: Bub1, Bub2, Bub3 (Hoyt et al., 1991).
These two seminal screens established the existence of a feedback mechanism
that arrests the cell cycle in mitosis in response to microtubule disruption and laid the
foundation for the field of study of the spindle assembly checkpoint. Following the initial
discovery of the first SAC genes, the loci were cloned and the proteins, biochemically
and cell-biologically characterized.
We now know that more proteins are required for or involved in checkpoint arrest
and silencing, including the motor proteins CENP-E, CENP-F and dynein, the dyneininteracting proteins Spindly and RZZ complex (Rod, Zwilch, ZW10), the Mad2-inhibitor
p31/Comet, the phosphatase PP1-gamma, as well as the mitotic kinases Mps1 and
Aurora B (Musacchio and Salmon, 2007; Musacchio, 2012).
7

Following initial discovery of checkpoint genes, researchers focused on examining
what the primary signal for the feedback mechanism is and how the signal is transduced
in the cytoplasm. Early studies showed that cells progress into anaphase after the last
chromosome has been properly attached, suggesting that non-bioriented chromosomes
produce a diffusible, “stop-anaphase” signal that prevents cell cycle progression, and
that even a single unattached kinetochore is sufficient to induce metaphase arrest
(Rieder et al., 1994; Rieder et al., 1995). We now understand that the presence of
unattached or improperly attached (i.e. non-bioriented) kinetochores acts as a primary
signal that is detected, transduced and amplified by checkpoint proteins into the
cytoplasmic “stop-anaphase” signal. Upon biorientation of all chromosomes, the
checkpoint is satisfied and the diffusible signal is disassembled, allowing the cell to
progress onto chromosome segregation (Musacchio and Salmon, 2007).
In the following sections, I shall explain how the checkpoint proteins interact with
non-bioriented chromosomes to detect, transduce, amplify and finally silence the
spindle assembly mechanism that inhibits APC/C-cdc20.

Molecular basis of checkpoint arrest
In order to progress into anaphase, the cell must degrade two key mitotic proteins:
cyclin B and securin. Cyclin B is the binding partner and activator of cyclin-dependent
kinase 1 (CDK1), the master regulator of mitotic entry and early mitosis. Securin is a
protein that inhibits the protease (separase) that cleaves the cohesion between the
sister chromatids. Once all chromosomes are bioriented, cyclin B and securin are
8

ubiquitylated

by

the

E3

ubiquitin

ligase

APC/C

(anaphase

promoting

complex/cyclosome) and thus targeted for degradation by the proteosome, allowing
progression into anaphase (Barford, 2012). Accordingly, the SAC prevents anaphase
progression until all chromosomes are bioriented by inhibiting the interaction of the
APC/C with its co-activator cdc20. By preventing the activation of the APC/C, the SAC
prevents the degradation of cyclin B and securin and thus keeps the cells in a state of
high CDK activity and cohesed chromosomes (Fig. 1.2).
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Figure 1.2 Spindle assembly checkpoint (SAC) simplified circuitry. The lack of
chromosome biorientation signals through the SAC to prevent progression into
anaphase. The mitotic checkpoint complex (MCC, composed of C-Mad2, BubR1 and
cdc20) inhibits cdc20 from co-activating the E3 ubiquitin ligase APC/C, preventing the
ubiquitylation and subsequent degradation of cyclin B and securin and maintaining the
cell in a metaphase state. Biorientation silences checkpoint signaling, allowing the
progression into anaphase. Green font indicates anaphase-promoting activities; red
font, anaphase-inhibiting ones.
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Detection of the primary signal
As mentioned above, the primary signal for spindle assembly checkpoint arrest is the
presence of non-bioriented chromosomes, i.e. those whose kinetochores are either
unattached by microtubules or improperly interacting with them. In fact, the
kinetochore—the complex multi-protein structures that assemble on centromeric DNA
at the start of mitosis and whose assembly is hierarchical and highly regulated, for
instance by the kinases Aurora B and Mps1—is not only the site of microtubule
attachment, but also the site of detection of the checkpoint primary signal (Cheeseman
and Desai, 2008; Santaguida and Musacchio, 2009; DeLuca and Musacchio, 2012).
Checkpoint

protein

Mad1-Mad2

tetramers

are

recruited

to

non-bioriented

kinetochores, after which they can start the primary signal transduction and
amplification that will lead to metaphase arrest (Hardwick and Murray, 1995; Chen et
al., 1996; Hardwick et al., 1996; Li and Benezra, 1996; Chen et al., 1998; Waters et al.,
1998). Mad1 and Mad2 are the main detectors of the primary signal, and their
kinetochore localization is sufficient to induce checkpoint arrest (this work, second
Chapter). Importantly, because Mad1-Mad2 recruitment to unattached kinetochores
occurs ‘by default’ (owing to kinetochore-localization sequences and mitotic kinase
phosphorylation), and because this recruitment occurs early in prometaphase when
most kinetochores are still unattached, the SAC is a constitutively active surveillance
mechanism that requires active silencing for cells to progress through mitosis.
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Transduction and amplification of the SAC primary signal.
Given that a single kinetochore can achieve the same outcome as every unattached
kinetochore and that the APC/C inhibitory signal must be detected throughout the
metaphase plate to prevent an unsynchronized anaphase onset, the SAC primary signal
must not only be transduced into a cytoplasmic signal, but also amplified.
In most signal transduction pathways, signal amplification is achieved by
enzymatic catalysis. In the SAC, amplification and maintenance of the anaphaseinhibitory signal is achieved by the combined action of checkpoint proteins such as
Mad1 and Mad2, together with mitotic kinases such as Aurora B and Mps1. Although
not a canonical enzyme, Mad1-bound Mad2 can indeed act as a de facto enzymatic-like
catalyst (Lad et al., 2009; Simonetta et al., 2009). Thanks to a wealth of cellular,
biochemical, biophysical and structural work, we now have a very detailed model (the
“Mad2 conformational activation” or “template model”) for how Mad1 and Mad2 act at
unattached kinetochores to transduce and amplify the primary signal of nonbiorientation into the diffusible anaphase-inhibitory signal (Luo and Yu, 2008).
Mad1 and Mad2 can interact all throughout the cell cycle, forming a tightly bound
tetramer consisting of a Mad1 dimer and two Mad2 molecules (Chen et al., 1999; Sironi
et al., 2002). During interphase, the Mad1-Mad2 tetramer rests in the nucleoplasmic
side of the nuclear membrane (Iouk et al., 2002; Lee et al., 2008). Upon nuclear
envelope breakdown, the Mad1-Mad2 tetramer is recruited to unattached
kinetochores, via Mad1’s kinetochore binding domain and its interactions with
kinetochore proteins such as Ndc80, aided by phosphorylation by Mps1 (Abrieu et al.,
12

2001; Martin-Lluesma et al., 2002; DeLuca et al., 2003). Cells have an excess of Mad2
relative to Mad1, and the ratio between the two is crucial to a robust checkpoint arrest
(Chung and Chen, 2002; Barnhart et al., 2011).
Remarkably, Mad2 exists in two topologically distinct, stable conformational states:
an open (O-Mad2) and a closed (C-Mad2) configuration, differing in the position of the
N- and C-terminal strands of its beta-sheet (Luo et al., 2004). In the open-to-closed
conversion, the N-terminal strand detaches from the beta sheet to form an extra turn
on the first alpha-helix. More notably, the two C-terminal beta strands detach from the
sheet, cross over and re-bind the beta sheet on the other side. This causes a loop to
traverse the body of the beta sheet, forming a structure reminiscent of a seat belt.
Open-Mad2 and C-Mad2 are at equilibrium with very slow inter-conversion rates; in
HeLa cells, open Mad2 is the predominant form (Luo et al., 2004). Only C-Mad2 can bind
cdc20 and hence ultimately lead to APC/C inhibition (Mapelli et al., 2007; Yang et al.,
2008; Luo and Yu, 2008). Therefore, C-Mad2 is the active conformer.
Interaction of O-Mad2 with Mad1 lowers the energetic barrier of the transition
between O-Mad2 and C-Mad2 (De Antoni et al., 2005; Yang et al., 2008). Therefore, the
Mad1-dimer-bound Mad2 species are two C-Mad2 molecules (i.e., the core tetramer
consists of a Mad1 dimer and two C-Mad2 protomers). These C-Mad2 molecules are
capable of recruiting O-Mad2 molecules from the cytoplasm and promoting their
conversion to C-Mad2 (active) molecules (Luo et al., 2004; De Antoni et al., 2005; Luo
and Yu, 2008). These processes are entirely catalytic and reversible, i.e. the rates of
inter-conversion are accelerated, but the equilibria are not altered. Since the Mad113

bound closed-Mad2 remains stably associated with the Mad1 dimer, kinetochorelocalized C-Mad2 acts as a catalyst for the conversion of a large number of cytoplasmic
O-Mad2 (Simonetta et al., 2009). These newly formed C-Mad2 molecules can bind and
inhibit cdc20. Although it is speculated that cdc20 binds to a high energy intermediate
(I-Mad2) that forms during the O-to-C-Mad2 conversion (as opposed to cdc20 binding to
a C-Mad2 that has been fully converted and released to the cytoplasm), this is still
unclear (Luo and Yu, 2008). Another point of debate is whether C-Mad2 in the
cytoplasm can also carry out an auto-amplification loop (converting more O-Mad2
molecules to the closed form), to further amplify the signal (De Antoni et al., 2005).
Although this is feasible in principle (and is supported by computational modeling
studies; Simonetta et al., 2009), there is no biological evidence for it. On the contrary,
recent studies in budding yeast indirectly suggest that there is no auto-amplification
Mad2 loop in the cytoplasm (Lau and Murray, 2012). This issue remains to be more
directly tested in yeast and in higher organisms. These uncertainties notwithstanding, it
is clear that the primary signal of non-biorientation is detected, transduced and
amplified by the kinetochore-bound Mad1-Mad2 core tetramer to lead to the inhibition
of cdc20-APC/C.
As described, this model relies entirely on Mad1 and Mad2 for the amplification of
the stop signal; there is no mention or need for the involvement of any of the
checkpoint kinases which are known to be essential for regulating checkpoint activity.
This simplification partially rests on the fact that in vitro studies with purified Mad1 and
Mad2 (and even purified chromosomes, without associated kinases) can catalyze the
14

production of the inhibitory signal by acting directly on Mad2 (Vink et al., 2006; Kulukian
et al., 2009). Moreover, given that checkpoint kinases such as Aurora B and Mps1 have
upstream roles in kinetochore and spindle assembly, it has been very difficult to
determine whether these kinases also have direct roles in checkpoint signaling,
downstream of checkpoint protein recruitment to the kinetochores (Meraldi et al.,
2004b; Lan and Cleveland; Ditchfield et al., 2003; Kallio et al., 2002; Hauf et al., 2003;
Petersen and Hagan, 2003; Pinsky et al., 2006; Emanuele et al., 2008; Vanoosthuyse and
Hardwick, 2009; Saurin et al. 2011). In Chapter 2, I shall describe and discuss the method
I designed to address this difficulty. My results, together with mounting evidence from
yeast, Xenopus and other human studies, make it now clear that Aurora B and Mps1 do
in fact have essential roles in the maintenance of checkpoint arrest (Kallio et al., 2002;
Petersen and Hagan, 2003; Emanuele et al., 2008; Vanoosthuyse and Hardwick, 2009;
Maldonado and Kapoor, 2011; Santaguida et al., 2011), indicating that checkpoint
signaling may not be as different from other signaling pathways as once thought (Figure
1.3).
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Figure 1.3 Schematic representation of spindle assembly checkpoint establishment
and maintenance. Mad1-C-Mad2 tetramers are recruited to unattached kinetochores.
Mad1-bound C-Mad2 catalyses the conversion of cytoplasmic O-Mad2 to C-Mad2. CMad2 binds cdc20 and, together with BubR1, forms the inhibitory MCC, which blocks
APC/C activation and, consequently, cyclin B and securin degradation. Catalytic activity
of checkpoint kinases such as Aurora B and Mps1 is also needed to maintain checkpoint
signaling. The full complement of their checkpoint substrates is unknown, but it includes
MCC components, likely, APC/C subunits and, speculatively, p31.
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APC/C inhibition by the checkpoint
How do checkpoint components inhibit cdc20 to prevent APC/C activation? Although CMad2 can bind and inhibit cdc20 by itself in vitro, in cells C-Mad2 forms a cdc20inhibitory mitotic checkpoint complex (MCC; Sudakin et al., 2001; Fig. 1.3). The MCC is
composed of cdc20 and C-Mad2, together with BubR1 and the accessory protein Bub3
(Sudakin et al., 2001; Chao et al. 2012). Importantly, both C-Mad2 and BubR1 can bind
and inhibit cdc20, and it has been shown in vitro and in yeast that these proteins act
synergistically to inhibit cdc20 and prevent anaphase progression (Fang, 2002; Tang et
al., 2001; Lau and Murray, 2012). The C-Mad2-BubR1-cdc20 trimer is indeed the most
downstream effector of the SAC (Lau and Murray, 2012). A recent structure of this
trimer confirmed and augmented previous biochemical studies and showed how the
inhibition of the APC/C co-activator takes place (Chao et al., 2012). BubR1 directly
inhibits cdc20-APC/C by using its pseudo-KEN box (one of the APC/C’s substrate
recognition sequences) to obstruct the degron recognition patch on cdc20. C-Mad2 aids
this interaction by optimally positioning BubR1’s pseudo-KEN box for cdc20 inhibition.
Moreover, C-Mad2’s interactions with cdc20 (which is, effectively, trapped by C-Mad2’s
“seat belt”) partially sequester cdc20’s APC/C interaction and activation motifs, further
contributing to cdc20 inhibition.
Recent studies have also shown that, although purified C-Mad2 and BubR1 can
inhibit APC/C-cdc20 in vitro, checkpoint kinase activity is needed to sustain these
interactions—and checkpoint arrest— in cells. For instance, Mps1-mediated
phosphorylation of C-Mad2 have recently been found necessary for checkpoint arrest
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maintenance, and a number of phosphorylation sites for Mps1 and other checkpoint
kinases have been found on other MCC and APC/C-cdc20 components (Tang et al., 2004;
King et al., 2007; Kang et al., 2008; Zich et al., 2012). This is, of course, consistent with
the fact that Aurora B and Mps1 activities are directly needed for checkpoint signaling
and strongly suggests that the MCC and APC/C-cdc20 may be the kinases’ cytoplasmic
substrates whose phosphorylation prevents cell cycle progression. Identifying the full
set of checkpoint kinase substrates is an important task for the full elucidation of the
mechanism of checkpoint arrest.
These remaining issues notwithstanding, the consensus is emerging that checkpoint
signal amplification and mitotic arrest is not only mediated by Mad2’s catalytic template
mechanism: enzyme catalysis by checkpoint kinases is also needed for the cytoplasmic
C-Mad2 molecules to associate with BubR1 and APC/C-cdc20 in a robust manner. Given
the importance of phosphorylation in the regulation of most other events in the cell
cycle, and the usefulness of enzymatic activity for signal amplification, this is not too
surprising.

Silencing of the checkpoint signal
Once all chromosomes have achieved bipolar attachment, the checkpoint must be
silenced. This allows the degradation of cyclin B and securin such that chromatids can be
segregated and anaphase, irreversibly initiated. In contrast to the numerous cellbiological, biochemical, and structural advances in our understanding of the
establishment of checkpoint arrest, the elucidation of checkpoint silencing pathways has
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lagged behind. In human cells, at least three different processes for SAC silencing have
been suggested. These include: motor-protein-based processes, such as the dyneindependent removal of checkpoint proteins from microtubule-attached kinetochores
(Howell et al., 2001) and the CENP-E-mediated silencing of BubR1 signaling (Mao et al.,
2005); mechanisms that involve inhibition of active SAC signaling proteins, such as the
p31/Comet-mediated, structural mimicry-based inhibition of “active” Mad2 (Xia et al.,
2004); pathways that mediate the chemical modification of checkpoint proteins, such as
the ubiquitylation (and ensuing degradation) of cdc20 (Reddy et al., 2007; Nilsson et al.,
2008), or the dephosphorylation of “key” substrates of mitotic kinases by phosphatases.
These processes contribute to SAC silencing both on the kinetochore and in the
cytoplasm, but their relative importance and interdependence are still not well
understood (Fig. 1.4).
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Figure 1.4 Schematic representation of spindle assembly checkpoint silencing
pathways. Upon biorientation, (a) dynein removes Mad1-C-Mad2 tetramers from
kinetochores, (b) p31 disassembles MCC and may also block O-Mad1-to-C-Mad2
catalysis at kinetochores (c), (d) phosphatase activity (PP1-gamma and perhaps others)
dephosphorylate checkpoint kinase substrates, both at the kinetochore and in the
cytoplasm, all of which relieves the inhibition on APC/C, allowing cyclin B and securin
degradation and, consequently, anaphase onset. For simplicity, other pathways such as
cdc20 ubiquitylation and CENPE-mediated BubR1 inhibition are not shown.
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Dynein stripping
At the kinetochore, the main checkpoint silencing mechanism is “dynein stripping”: the
motor-protein dynein mediates the removal of Mad1-Mad2 tetramers and other
checkpoint proteins towards spindle poles. Early in mitosis, dynein is recruited to
unattached kinetochores by the protein Spindly and the RZZ complex (Starr et al., 1998;
Griffis et al., 2007; Inoue et al., 2008). Upon chromosome biorientation, dynein is
activated by phospho-regulated mechanism and the “stripping” process begins. Because
dynein depletion or reduced recruitment to kinetochores causes a delay in mitotic
progression, it was proposed that dynein contributes to SAC silencing (Faulkner et al.,
2000; Howell et al., 2001; Stehman et al., 2007). However, it has been shown that
detectable levels of Mad2 remain at attached kinetochores and that depletion of Mad2
from kinetochores is not required for anaphase onset (Canman et al., 2002). Similarly, in
Chapter 2, I show that checkpoint arrest can be overcome by kinase inhibition in the
cytoplasm, regardless of the continued localization of Mad1-Mad2 tetramers at
kinetochores. Hence, the extent to which, and the kinetics with which, dynein stripping
contributes to SAC silencing are still an unresolved question. To try to examine these
matters, I joined an ongoing collaboration with Dr James Chen’s laboratory (Stanford),
who was in the process of validating and characterizing the first specific small molecule
dynein inhibitor (Firestone et al., 2012). This work is discussed in Chapter 3.
Ubiquitylation, degradation and p31/Comet
In the cytoplasm, a variety of inter-related mechanisms have been proposed to play
roles in checkpoint silencing. For instance, APC/C-mediated proteolysis of cyclin B,
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securin, and Mps1 is thought to contribute to the maintenance of SAC silencing during
anaphase, once tension is lost (Palframan et al., 2006). Similarly, auto-ubiquitylation of
cdc20 is thought to promote its dissociation from Mad2 and the MCC to overcome the
arrest. Interestingly, cdc20 auto-ubiquitylation-mediated turnover is also thought to be
active throughout SAC arrest, and this is thought to allow rapid disengagement from
MCC and checkpoint silencing once biorientation is achieved (Mansfeld et al., 2011;
Reddy et al., 2007; Nilsson et al., 2008).
Another protein that is thought to be involved in MCC disassembly and the release
of cdc20 inhibition is the “C-Mad2 inhibitor” p31/Comet. This protein is structurally
similar to C-Mad2 and can bind both Mad1- and cdc20-bound C-Mad2; however, it does
not support further Mad2 O-to-C conversion (Yang et al., 2007). Therefore, p31/Comet
is thought to provide a “brake” to the Mad2 template amplification at the kinetochore.
Furthermore, by binding to cdc20-bound C-Mad2, p31/Comet not only thwarts CMad2’s APC/C inhibitory activity, but also facilitates the disassembly of C-Mad2-cdc20
complexes (in part because C-Mad2 and p31/Comet share a common binding site on
cdc20; Yang et al., 2007). P31/Comet also promotes the autoubiquitylation and
degradation of cdc20 during prometaphase, a homeostatic mechanism to maintain
steady states of MCC-cdc20 that is thought to promote timely exit from mitosis, even if
not needed for SAC silencing per se (Varetti et al., 2011). The full details of p31/Comet
activity and its regulation, the process of cdc20 autoubiquitylation during metaphase
and anaphase and the interactions and relative contributions between these two
processes remain to be fully elucidated.
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PP1-gamma-mediated dephosphorylation
Finally, another mechanism involved in SAC silencing is the dephosphorylation of
checkpoint effectors. Although intuitively obvious that the kinase phosphorylations
necessary for SAC arrest must be reversed for progression into anaphase, it has only
been recently that the process began to be clarified. Dissection of this mechanism has
greatly benefited from studies in yeast, organisms in which, notably, most of the other
silencing pathways are currently thought to be non-essential or non-existent. Studies in
budding and fission yeast have shown that the phosphatase PP1-gamma is essential for
checkpoint silencing (Pinsky et al., 2009; Vanoosthuyse and Hardwick, 2009). Further
studies in yeast and vertebrate cells showed that PP1-gamma acts not only in the
cytoplasm, but also at the kinetochore, and revealed that a bi-stable PP1/AuroraB
mechanism operates to recruit PP1-gamma when kinetochores have been attached by
microtubules (Liu et al., 2010; Meadows et al., 2011; Rosenberg et al., 2011). These
results began to uncover how checkpoint silencing is coupled to chromosomal
biorientation, a crucial question that remains unanswered. Determining the identity of
all checkpoint PP1 substrates, as well as the interplay between PP1-gamma-mediated
silencing and the other mechanisms described above will also be important questions
for future research.

Unresolved questions and motivation for thesis research
Although we know a lot of the molecular details of the checkpoint mechanism, there are
still many basic questions that have not been studied in detail. For instance: we know
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that Mad1-Mad2’s dynamic localization (at unattached kinetochores and removed upon
biorientation) strongly correlates with spindle checkpoint activity, but it is unknown
whether this kinetochore localization is necessary and/or sufficient for checkpoint
arrest. Would the sustained presence of Mad1-Mad2 at kinetochores be sufficient to
maintain checkpoint arrest, even if all chromosomes were bioriented? If so, would
removal of Mad1-Mad2 from kinetochores be sufficient to silence the checkpoint? Some
evidence that suggests this removal is not necessary (Canman et al., 2002). Otherwise,
what is the major checkpoint silencing mechanism?
With respect to necessity of kinetochore localization of Mad1-Mad2, what are the
roles of kinetochores in checkpoint arrest? In other words, could Mad1-Mad2 induce
robust checkpoint arrest from ectopic locations, such as other chromosomal sites, or
even the cytoplasm? We know that kinetochores are necessary for checkpoint signaling:
kinetochore-null cells cannot establish the SAC and only kinetochore-bound Mad1-Mad2
can sustain a robust O-to-C-Mad2 catalytic amplification (Janke et al., 2001; Kline et al.,
2006; Salmon and Mussachio, 2007). On the other hand, some evidence indicates that,
if Mad1-Mad2 cannot be recruited to kinetochores (for instance, due to Bub3 depletion
in budding yeast), checkpoint arrest can nevertheless be established from the
cytoplasm, albeit transiently and weakly (Windecker et al., 2009). Moreover,
overexpression overexpression of Mad2 induces metaphase arrest in a variety of
systems, including human cells (Chen et al., 1998; Sironi et al., 2001; Howell et al., 2004;
De Antoni et al, 2005). This suggests that the role of kinetochores may mainly be to act
as recruitment platforms that induce Mad1-Mad2 clustering to establish a robust
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checkpoint arrest. Could we activate checkpoint by artificially or ectopically clustering
Mad1-Mad2?
If dynamic localization of Mad1-Mad2 is necessary for function, if their kinetochore
localization is sufficient to induce checkpoint arrest and if, therefore, perturbing
localization has downstream effects on checkpoint signaling, then we should be able to
bypass the requirement of a primary signal for the recruitment of Mad1-Mad2 and
ensuing checkpoint arrest by artificially tethering the proteins to kinetochores. If we
could develop a system that, by controlling Mad1 localization, controls checkpoint
signaling regardless of detection of the primary signal, then this uncoupling of
checkpoint activity from chromosome biorientation would enable us to study details of
checkpoint signaling and silencing that are not possible to study with other methods.
For instance, we could examine the roles of “checkpoint” kinases in checkpoint
signaling. Because kinases such as Aurora B and Mps1 have a variety of functions in
processes that are necessary to be in place for checkpoint signaling to occur (e.g.
assembling the spindle and kinetochores, recruiting checkpoint proteins, controlling
kinetochore-microtubule interactions), it has been very difficult to dissect whether
these kinases also had bona fide roles in checkpoint establishment and maintenance, or
if the checkpoint-abrogating effects seen upon their inhibition was merely due to the
disruption of their necessary “upstream” functions.
In this thesis work, I have tackled some of these questions. In Chapter 2, I present an
approach that, by constitutively localizing Mad1 at kinetochores via a fusion to the
kinetochore protein Mis12, allows us to uncouple checkpoint signaling from
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chromosome biorientation. I used this system to examine the roles of different
checkpoint kinases in the maintenance of the arrest downstream of Mad1-Mad2
kinetochore recruitment. I also used similar approaches of fusing Mad1 to nonkinetochore chromosomal proteins to examine whether checkpoint arrest can be
established ectopically. In Chapter 3, I describe my characterization of the mitotic
effects of the small molecule ciliobrevin D, the first specific inhibitor of the motor
protein dynein. This work, which was part of a collaboration with James Chen’s
laboratory (Stanford University), sought to establish this small molecule as a tool for the
study of checkpoint silencing. In Chapter 4, I conclude with a discussion of possible
future directions of my findings, as well as of the spindle assembly checkpoint field in
general. I have also included an appendix with preliminary results for follow-up studies
to the Mis12-Mad1 project.
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Chapter 2: Constitutive Mad1
targeting to kinetochores
uncouples checkpoint signaling
from chromosome biorientation
Summary
Accurate chromosome segregation depends on biorientation, whereby sister chromatids
attach to microtubules emanating from opposite spindle poles. The spindle assembly
checkpoint is a conserved surveillance mechanism in eukaryotes that inhibits anaphase
onset until all chromosomes are bioriented (Hartwell and Weinert, 1989; Rieder et al.,
1994; Musacchio and Salmon, 2007). In current models, the recruitment of Mad2, via
Mad1, to improperly attached kinetochores is a key step needed to stop cell cycle
progression (Musacchio and Salmon, 2007; Chen et al., 1996; Li and Benezra, 1996;
Chen et al., 1998). However, it is not known if the localization of Mad1-Mad2 to
kinetochores is sufficient to block anaphase. Furthermore, it is unclear if other signaling
proteins (e.g. Aurora B kinase; Meraldi et al., 2004b) that regulate chromosome
biorientation have checkpoint functions downstream of Mad1-Mad2 recruitment to
kinetochores or if they act upstream to merely quench the primary error signal (Pinsky
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and Biggins, 2005; Pinsky et al., 2006). To address both these issues, I engineered a
Mad1 construct which, unlike endogenous Mad1, localizes to kinetochores that are
bioriented. In this Chapter, I show that Mad1’s constitutive localization at kinetochores
is sufficient for a metaphase arrest that depends on Mad1-Mad2 binding. By uncoupling
the checkpoint from its primary error signal, I show that Aurora kinase, Mps1 and
BubR1, but not Polo-like kinase, are needed to maintain the checkpoint arrest even
when Mad1 is present on bi-oriented kinetochores. Together, my data suggest a model
in which the biorientation errors, which recruit Mad1-Mad2 to kinetochores, may be
signaled not only through Mad2’s templated activation dynamics, but also through the
activity of widely conserved kinases, to ensure the fidelity of cell division.

Rationale
The spindle assembly checkpoint, which can block anaphase when even a single
chromosome is improperly attached to spindle microtubules, depends on Mad1 and
Mad2 (Musacchio and Salmon, 2007). In current models of checkpoint signaling, a key
step is the recruitment of Mad1 and Mad2 to kinetochores that lack proper microtubule
attachments. Mad1 forms a homodimer that binds two Mad2 molecules, forming a
“core tetramer”, which “templates” the conversion of cytosolic Mad2 from an inactive
“open” conformation to a “closed” form (Fig. 2.1; Sironi et al., 2002; Luo and Yu, 2008;).
A diffusible cytosolic complex, which includes closed-Mad2, blocks anaphase
progression by inhibiting the activation of APC/C, the E3 ubiquitin ligase required for
anaphase (Musacchio and Salmon, 2007; Hardwick et al., 2000; Sudakin et al., 2001).
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The binding of microtubules to the kinetochore removes Mad1-Mad2 and thereby
suppresses the generation of closed-Mad2 (Fig. 2.1; Musacchio and Salmon, 2007). As
Mad1, unlike Mad2, is not expected to undergo conformational dynamics at kinetochore
sites (Sironi et al., 2002; Luo and Yu, 2008) and is not a component of the soluble
complex that inhibits APC/C activation (Hardwick et al., 2000; Sudakin et al., 2001), we
envisioned that engineering the constitutive localization of Mad1 to kinetochores may
dissociate checkpoint signaling from the status of biorientation, the primary error signal.
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Figure 2.1 Experimental design to recruit Mad2 to kinetochores independently of
microtubule attachment. (a) Endogenous Mad1 (grey) localizes to kinetochores that are
not attached to microtubules and recruits Mad2 (dark green), forming a Mad1-Mad2
core tetramer. The Mad1-bound Mad2 catalytically converts open-Mad2 molecules
(dark green square) into closed-Mad2 molecules (dark green circle). Microtubule (light
green) binding displaces Mad1, and therefore Mad2, from kinetochores. (b) We fused
Mad1 to Mis12 (red), a protein whose kinetochore localization is microtubule-binding
independent. This construct could retain Mad1 (and Mad2) on microtubule-attached
kinetochores.
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Constitutive kinetochore localization of Mad1 induces Mad2-dependent
checkpoint arrest
To localize Mad1 at all kinetochores, I considered fusing it to Mis12, a kinetochore
resident protein and member of the KMN complex, a core component of the outer
kinetochore (Cheeseman et al., 2004). Since KMN proteins are implicated in recruiting
endogenous Mad1 to kinetochores (Santaguida and Musacchio, 2009), I reasoned that
engineered fusion constructs could be designed to achieve a kinetochore localization of
Mad1 similar to the endogenous one, but independent of kinetochore-microtubule
attachment. A fusion construct with an N-terminal mCherry tag, followed by a flexible
linker, Mis12, a second flexible linker and Mad1 at the C-terminus— such that
interactions with Mad2 would likely remain unaffected— was found to express at levels
that were similar to endogenous Mad1 (Fig. 2.2a). In live cells, I found that mCherryMis12-Mad1 localized to puncta on the chromosomes, as would be expected for a
kinetochore-targeted protein, in mitotic and interphase cells (Fig. 2.2b). Unlike
endogenous Mad1, this signal was observed on chromosomes at the metaphase plate,
suggesting that the fusion construct localized at properly bioriented chromosomes. In
addition, immunofluorescence analysis of CREST and tubulin signals in fixed cells
revealed the robust localization of mCherry-Mis12-Mad1 at outer kinetochores that
were aligned at the metaphase plate and had microtubule bundles with intensities
similar to that of control mitotic cells (Fig. 2.2c-e). To visualize interactions between
mCherry-Mis12-Mad1 and Mad2 in live cells, I generated a HeLa cell line that stably
expresses GFP-Mad2 and transiently transfected it with mCherry-Mis12-Mad1. I
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incubated these cells in the proteosome inhibitor MG132, such that metaphase spindles
would accumulate and the endogenous Mad1 would be removed from the
kinetochores. Live imaging revealed that GFP and mCherry signals co-localized on all
chromosomes of the mCherry-positive cells, even if they had tight metaphase plates
that persisted for hours (Fig. 2.2f-g). These results show that fusion of Mad1 to Mis12
achieves constitutive kinetochore localization of Mad1 and Mad2, regardless of
microtubule attachment.
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Figure 2.2 A mCherry-Mis12-Mad1 fusion can recruit Mad2 to kinetochores
independently of microtubule attachment. (a) The expression levels of mCherry-Mis12Mad1, mCherry-Mis12-Mad1 K541A L543A (AA) and mCherry-Mad1 (upper bands) are
similar to the levels of endogenous Mad1 (lower bands), by immunoblotting. (b)
Analysis of mCherry-Mis12-Mad1 localization in live cells. Differential interference
contrast (DIC) and mCherry-fluorescence images of a mCherry-Mis12-Mad1-transfected
cell at metaphase. (c-e) mCherry-Mis12-Mad1 localizes at kinetochores, even when they
are attached to microtubules. Immunofluorescence images of HeLa (control) (c) and
mCherry-Mis12-Mad1-transfected (d) cells, stained for DNA, tubulin, CREST and
mCherry. Overlay shows tubulin (green), CREST (blue) and mCherry (red). Insets
(selected optical sections) (e) show individual microtubule-attached kinetochores from
(d), 5-fold magnification. (f) Analysis of Mad2 recruitment by mCherry-Mis12-Mad1. DIC,
mCherry- and GFP-fluorescence images of a HeLa cell stably-expressing GFP-Mad2,
transfected with mCherry-Mis12-Mad1 are shown. MG132 (10 μM, 1 h) was used to
accumulate live cells at metaphase with many microtubule-attached chromosomes. (g)
The metaphase arrest induced by mCherry-Mis12-Mad1 is persistent. Live mCherryfluorescence images of a mCherry-Mis12-Mad1-transfected HeLa cell at metaphase are
shown. The indicated times (h: min) are relative to time of transfection. Scale bar, 5 μm.
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I then investigated the effects of the constitutively kinetochore-localized Mad1Mad2 on cell cycle progression. Compared to untransfected control cells, I observed a
~5-fold increase (27.6% ± 2%) in the mitotic index of the mCherry-positive cells, 24 h
post-transfection. Of these mitotic cells, 95.6% (± 1.7%) were at metaphase (Fig. 2.3a).
Thirty hours after transfection, the mitotic index of the mCherry-Mis12-Mad1transfected population increased to 43% (± 6.2%), indicating that this metaphase arrest
was persistent. Similar results were found with live imaging experiments (Fig. 2.2g). In
addition, mCherry-Mis12-Mad1 transfected into immortalized RPE-1 cells also resulted
in a persistent metaphase arrest (Fig. 2.3b). To confirm that the increased mitotic index
seen in mCherry-Mis12-Mad1-transfected cells was not caused by overexpression of
Mad1 alone, I transfected cells with mCherry-Mad1. This construct was expressed at
levels similar to that of mCherry-Mis12-Mad1 (Fig. 2.2a), and the transfected population
did not show an increase in the mitotic index (Fig. 2.3c). This suggests that it is the
kinetochore targeting of the forced-localized Mad1, and hence Mad2, that is responsible
and sufficient for inducing a persistent metaphase arrest.
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Figure 2.3 Constitutive kinetochore localization of Mad1 causes a persistent, Mad2dependent metaphase arrest. (a) Analysis of mitotic index and phenotypes in HeLa,
mCherry-Mis12-Mad1- and mCherry-Mis12-Mad1 AA- transfected cells. Cells were fixed
24 h and 30 h after transfection. (b) Analysis of mitotic index of mCherry-Mis12-Mad1and mCherry-Mis12-Mad1 AA- transfected, or untransfected RPE-1 cells. Cells were
fixed 48 h after transfection. (c) Analysis of mitotic index in mCherry-Mad1-transfected
and untransfected HeLa cells. Cells were fixed 24 h after transfection. For (a-c),
mCherry, tubulin and DNA staining (not shown) was used to determine mitotic index
and fraction of cells in metaphase, anaphase and all other mitotic states (n= 3
independent experiments, > 400 cells counted per condition per time). (d) The increase
in mitotic index induced by mCherry-Mis12-Mad1 is Mad2-dependent. HeLa cells were
transfected with small-interfering RNA against Mad2 or GFP, 24 h before transient
transfection with mCherry-Mis12-Mad2 or mCherry-Mis12-Mad1-AA, or no transfection.
Mitotic indices were determined after another 24 h (n= 3 independent experiments, >
250 cells counted per condition per time). (e-g) mCherry-Mis12-Mad1 AA localizes at
kinetochores in interphase (e), metaphase (f) and anaphase (g). Staining for DNA,
tubulin, CREST and mCherry is shown. (h) mCherry-Mis12-Mad1 AA does not prevent
the completion of mitosis. mCherry fluorescence images of a live cell are shown. The
indicated times (min) are relative to the first frame (prometaphase). (i-k) Expression of
mCherry-Mis12-Mad1 and mCherry-Mis12-Mad1 AA are similar, by quantification of
normalized, corrected fluorescence levels of mCherry by immunoblotting (n= 3
independent experiments) (i), of mCherry in whole cells by live imaging (n= 2
independent experiments, > 14 cells counted per condition per time) (j) and of mCherry
at individual kinetochores by immunofluorescence (n= 2 independent experiments, > 3
kinetochores counted per cell, 69 kinetochores per condition in total) (k). (l-m) mCherryMis12-Mad1-AA localizes at kinetochores, but does not recruit GFP-Mad2. mCherry- (l)
and GFP- (m) fluorescence images of a mCherry-Mis12-Mad1-AA transfected cell at
metaphase. MG132 (10 μM, 1 h) was used to accumulate live cells at metaphase with
many microtubule-attached chromosomes. Scale bar, 5 μm. Average ± s.e.m. shown.
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Next, I analyzed whether this mitotic index increase was a bona fide, Mad2dependent checkpoint arrest in two ways. First, I used RNA interference (RNAi) to
deplete Mad2. I observed a significant decrease in the mitotic index of the mCherryMis12-Mad1 population upon transfection with Mad2 siRNA (two-tailed T-test, p=0.026;
Fig 2.3d). Second, I used a Mad1 K541A L543A mutant construct (hereafter, mCherryMis12-Mad1 AA), which does not interact with Mad2 owing to mutations in the Mad2binding motif (Sironi et al., 2002). I found that the mCherry-Mis12-Mad1 AA fusion
localized at kinetochores both in mitotic and interphase cells (Fig. 2.3e-h) and expressed
at similar levels to those of mCherry-Mis12-Mad1 (Fig. 2.2a, 2.3i-k). As expected, I did
not detect co-localization of mCherry-Mis12-Mad1 AA and GFP-Mad2 (Fig. 2.3l-m). The
mitotic index of cells transfected with this “mutant” construct was 12.7% (± 1.7%; Fig.
2.3a), which was significantly different from mCherry-Mis12-Mad1-transfected cells
(two-tailed T-test, p=0.005). Moreover, mCherry-Mis12-Mad1 AA-positive cells divided
without appreciable chromosome segregation defects (Fig. 2.3g-h). Together, these
results indicate that the increase in the mitotic index resulting from mCherry-Mis12Mad1 expression is dependent on Mad2-binding.

Mis12-Mad1 does not induce overt alterations in kinetochore structure or
function
I then examined if the prolonged mitotic arrest was due to indirect effects on
kinetochore structure and kinetochore-microtubule binding. First, I used cold treatment
to analyze the stability of kinetochore-microtubule attachments in mCherry-Mis1238

Mad1 and -Mad1-AA- expressing cells. Immunofluorescence showed the presence of
cold-stable kinetochore-microtubule bundles, with co-localizing mCherry and CREST
signals at the kinetochore ends (Fig. 2.4c-f). These cold-stable microtubules had
organizations that were indistinguishable from those in control cells (Fig. 2.4a-b).

Figure 2.4 Analysis of cold-stable microtubules shows that forced kinetochore
localization of Mad1 does not disrupt microtubule attachment. HeLa (a), mCherryMis12-Mad1- (c) or mCherry-Mis12-Mad1-AA-transfected (e) cells were incubated in
MG132 (10 μM, 1 h) to accumulate cells at metaphase and were then placed on ice (10
min) before fixation. Cells were stained for DNA, CREST (blue), mCherry (red) and
tubulin (green). Individual channels and an overlay are shown. Insets (selected optical
sections) (b, d, f) show individual cold-stable microtubule-attached kinetochores (4-fold
magnification). Scale bar, 5 μm.
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Next, I analyzed the localization of p150Glued, CENP-E, Bub1, ROD and ZW10—
checkpoint proteins that reside at the kinetochore corona. Since kinetochore assembly
is hierarchical, correct recruitment of corona components suggests proper kinetochore
assembly (Cheeseman et al., 2004; Cheeseman and Desai, 2008). These checkpoint
proteins are recruited to kinetochores that have not yet bioriented and are completely
or partially removed from those sites upon biorientation, in unperturbed mitotic cells
(Musacchio and Salmon, 2007; Hoffman et al., 2001; Karess, 2005). I first exposed the
cells to the microtubule depolymerizing drug nocodazole to suppress biorientation.
P150Glued, CENP-E, Bub1, Rod and ZW10 were all seen on unattached kinetochores, both
in mCherry-Mis12-Mad1-expressing and control cells (Fig. 2.5a-e, first to third columns).
Additionally, p150Glued and CENP-E recruitment was also undisrupted in nocodazoletreated mCherry-Mis12-Mad1 AA-transfected cells (Fig. 2.5f-g). I then examined the
localization of these proteins on otherwise unperturbed, bioriented mCherry-Mis12Mad1-positive kinetochores. Immunofluorescence revealed that the removal (or
reduction) of each of these proteins was consistent with published data on their
localization on bioriented chromosomes (Fig. 2.5a-e, fourth and fifth columns).
Together, these data suggest that there are no overt dominant-negative effects on
kinetochore structure or microtubule attachments caused by mCherry-Mis12-Mad1.
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Figure 2.5 Analysis of localization of checkpoint proteins in cells with mCherry-Mis12Mad1 shows that forced kinetochore localization of Mad1 does not disrupt
kinetochore structure. (a-g) HeLa, mCherry-Mis12-Mad1- (a-e) and mCherry-Mis12Mad1-AA- (f, g) transfected cells were incubated in nocodazole (1 μg ml-1, 45 min; a-e
first to third columns; f, g) or left unperturbed (a-e fourth and fifth columns). Cells were
stained

for

DNA,

CREST,

mCherry

and

the

relevant

checkpoint

protein.

Immunofluorescence images show staining for mCherry and p150 Glued (a, f), CENP-E (b,
g), Bub1 (c), ROD (d) or ZW10 (e). Scale bar, 5 μm.
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Constitutive localization of Mad1 to non-kinetochore locations does not
induce checkpoint arrest
Next, I examined whether it was the kinetochore location of Mad1 that was necessary
for such an arrest, by force-localizing Mad1 to two different chromosomal locations.
First, I mis-localized Mad1 all along chromosomes by fusing it to histone H2B. The
mCherry-H2B-Mad1 fusion showed the expected localization (Fig. 2.6a-i) and did not
have dominant-negative effects (Fig. 2.6d-e). mCherry-H2B-Mad1-expressing cells were
able to undergo anaphase normally (Fig. 2.6h-i) and the mitotic index of this population
was indistinguishable from that of the control (Fig. 2.6j; two-tailed T-test, p=0.20). To
confirm that, despite not having apparent mitotic effects, mCherry-H2B-Mad1 indeed
interacted with Mad2, I transfected the construct into the GFP-Mad2 line. I found that
mCherry-H2B-Mad1 and GFP-Mad2 co-localized throughout all chromosomes in
interphase and mitosis, including anaphase (Fig. 2.6k-p). This suggests that
chromosomal recruitment of Mad2 is not sufficient for establishing checkpoint arrest.
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Figure 2.6 Forced localization of Mad1 to chromosome arms by fusion to H2B recruits
Mad2, but does not affect mitosis. HeLa cells (a-e) or HeLa cells stably expressing GFPMad2 (f-p) were transfected with mCherry-H2B-Mad1 and processed 48 h later. (a) GFPMad2

co-localizes

with

mCherry-H2B-Mad1

throughout

chromosome

arms.

Immunofluorescence images of a chromosome spread show staining for DNA, mCherry
and GFP. (b) mCherry-H2B-Mad1-transfected cells were incubated in nocodazole (1
μg/ml, 45 min) and stained for DNA, mCherry, CREST and CENP-E. Insets (selected
optical sections) (c) show various kinetochores where CENP-E crescents are observed (4fold magnification). (d) Analysis of cold-stable microtubules. mCherry-H2B-Mad1transfected cells were incubated in MG132 (10 μM, 1 h) to accumulate cells at
metaphase and were then placed on ice (10 min) before fixation. Cells were stained for
DNA, CREST, mCherry and tubulin Insets (selected optical sections) (e) show individual
cold-stable microtubule-attached kinetochores (4-fold magnification). (f-p) Expression of
mCherry-H2B-Mad1 does not affect mitotic progression. DIC (f, h, k, n), mCherry- (g, i, l,
o) and GFP-fluorescence (m, p) images of an interphase cell (f, g), a prometaphase cell
(k-m) and a cell undergoing anaphase (h, i, n-p) are shown. (j) Mitotic indices were
calculated by analyzing mCherry, tubulin and DNA staining (n= 3 independent
experiments, > 350 cells counted per condition per time). Scale bar, 5 μm. Average ±
s.e.m. shown.

44

45

Second, I mis-localized Mad1 at centromeres, via fusion with CENP-B’s centromeretargeting domain. Unexpectedly, this fusion protein had deleterious effects on
kinetochore-microtubule attachments (Fig. 2.7a-g). Although some cells achieved
apparent biorientation, live-cell imaging revealed that the majority of these metaphase
plates subsequently became mis-aligned, or transitioned into anaphase with numerous
lagging chromosomes (Fig. 2.7h-i). Therefore, the use of this construct to dissect
checkpoint signaling from chromosome biorientation was unfeasible. Together, these
data suggest that the kinetochore represents a specialized chromosomal location for
proper Mad1-Mad2 signaling.
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Figure 2.7 Fusion of Mad1 to CENP-B’s centromere targeting domain has deleterious
effects on microtubule attachment. (a-c) mCherry-CENP-B(aminoacids 1-158)-Mad1
localizes at centromeres in interphase (a) and mitotic (b, c) transfected HeLa cells.
Mitotic cells with aligned (b) and misaligned chromosomes (c) are shown.
Immunofluorescence images show staining for DNA, tubulin, CREST and mCherry. (d)
Mitotic index of HeLa and mCherry-CENP-B-Mad1-transfected cells. (e) Comparison of
abnormal mitotic phenotypes in HeLa, mCherry-Mis12-Mad1-, mCherry-Mis12-Mad1
AA- and mCherry-CENP-B-Mad1-transfected cells. mCherry, tubulin and DNA staining
was used to calculate mitotic index and fraction of cells with multipolar spindles and
misaligned chromosomes (n= 4 independent experiments, > 100 mitotic cells counted
per condition per time). (f-g) Analysis of cold-stable microtubules. mCherry-CENP-BMad1 transfected cells were incubated in MG132 (10 μM, 1 h) to accumulate cells at
metaphase and were then placed on ice (10 min) before fixation. Immunofluorescence
images show staining for DNA, CREST, mCherry and tubulin, for two example cells. (h-i)
Mitotic time-lapses of cells expressing mCherry-CENP-B-Mad1. Two example cells are
shown where chromosomal alignment is transiently achieved before gross misalignment (h) or mis-segregation in anaphase (i). DIC and mCherry channels are shown.
Time (in minutes) is relative to the first frame. Scale bar, 5 μm. Average ± s.e.m. shown.
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Using Mis12-Mad1 as a tool to examine kinase contributions to checkpoint
signaling

Positive and negative “control” kinases
Next, I used the kinetochore-localized Mad1 constructs to dissect the roles of
checkpoint kinases in maintaining checkpoint arrest. Forced kinetochore-localization of
Mad1 allows us to bypass the need for Mad1 and Mad2 recruitment to the kinetochore
to establish checkpoint arrest and hence to dissect the requirements of checkpoint
signaling upstream and downstream of Mad1/Mad2 recruitment. If activity of a
checkpoint kinase were needed upstream Mad1/Mad2 recruitment, forced localization
of Mad1 should bypass the need for such activity, and inhibition of the kinase should
not alter the checkpoint arrest caused by Mis12-Mad1. On the other hand, if kinase
activity were needed downstream of Mad1/Mad2 recruitment in order to maintain the
checkpoint arrest, then inhibition of kinase activity should abrogate the arrest and cause
a reduction in the mitotic index, regardless of the forced localization of Mad1.
I first examined the contributions of BubR1, a conserved cell cycle kinase that
regulates kinetochore-microtubule attachment (Musacchio and Salmon, 2007), that has
roles as a kinetochore-independent “timer” that sets the length of mitosis (Meraldi et
al., 2004a) and that is also a component of the soluble complex that inhibits APC/Ccdc20 (Sudakin et al., 2001). Because of these functions, I predicted that BubR1
inhibition would override the arrest induced by mCherry-Mis12-Mad1. Owing to the lack
of available BubR1 chemical inhibitors, I depleted the kinase with RNAi. Knockdown led
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to a significant reduction in the mitotic index (two-tailed T-test, p=0.013) and an
increase in the percentage of anaphase cells of the mCherry-Mis12-Mad1 population
(Fig. 2.8a). Together with previous studies (Musacchio and Salmon, 2007; Sudakin et al.,
2001; Meraldi et al., 2004a), our findings are consistent with BubR1 being necessary for
checkpoint signaling downstream of Mad1-Mad2.
I then used this assay to examine the contributions of Polo-like kinase (Plk1) to
checkpoint signaling. Plk1 is another widely conserved, cell cycle kinase involved in a
variety of cell-cycle processes, including the regulation of kinetochore-microtubule
attachments (Petronczki et al., 2008). Inhibition of Plk1 activity with its selective
inhibitor BI2536 did not result in a reduction of the mitotic index of the mCherry-Mis12Mad1 population, or in the appearance of anaphase cells (Fig. 2.8b). These findings are
consistent with other studies of Polo-like kinases (Petronczki et al., 2008) and show that,
although Plk1 is required for the regulation of chromosome biorientation, it is not
directly involved in maintaining the checkpoint signals required for a prolonged mitotic
arrest.
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Figure 2.8 Inhibition of BubR1, but not of Plk1, is sufficient for entry into anaphase in
cells expressing mCherry-Mis12-Mad1.(a-b) Analysis of mitotic index and phenotypes in
HeLa (control), mCherry-Mis12-Mad1- and mCherry-Mis12-Mad1 AA- transfected cells
upon BubR1 depletion (a) or Polo-like kinase (b). Cells were transfected with siRNA
against GFP (control) or BubR1 (a), or incubated in DMSO, BI2536 (80 nM, 90 min before
fixation) (b). mCherry, tubulin and DNA staining was used to calculate mitotic index and
fraction of cells in metaphase, anaphase and all other mitotic states (a) or with
monopolar spindles, in anaphase or all other mitotic states (b) (n= 3 independent
experiments, > 350 cells counted per condition per time). Average ± s.e.m. shown.
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Kinases potentially directly involved in checkpoint signaling
Next, I used our assay to dissect the requirement for Mps1 and Aurora B in the
maintenance of the checkpoint arrest. Both of these conserved kinases are involved in
the recruitment of key checkpoint components to unattached kinetochores and in the
regulation of the correction of erroneous microtubule attachments for the attainment
of biorientation, in a variety of organisms (Meraldi et al., 2004b; Lan and Cleveland,
2010). Although some discrepancies exist, current models agree that Aurora B and Mps1
act in a common network of mitotic signaling (Lan and Cleveland, 2010; Saurin et al.,
2011). Mps1 accumulates at unattached kinetochores, and biorientation depletes the
kinase from kinetochores (Jelluma et al., 2010). Recent findings suggest that Mps1 has
cytosolic as well as kinetochore-specific functions (Maciejowski et al. 2010; Lan and
Cleveland, 2010). I reasoned that our assay would allow us to examine the requirement
for cytosolic Mps1 in maintaining the checkpoint arrest when chromosomes are
bioriented, and therefore independently of its kinetochore functions. To do this, I used
two unrelated Mps1 inhibitors—Mps1-IN-1 (Kwiatkowski et al. 2010) and reversine
(Santaguida et al. 2010)—in parallel experiments, to reduce the likelihood of
overlapping off-target effects of either inhibitor. After a two-hour incubation with
Mps1-IN-1, the mCherry-Mis12-Mad1 population showed a significant reduction in
mitotic index (Fig. 2.9a; two-tailed T-test, p=0.0069) and a corresponding increase in
anaphase cells (two-tailed T-test, p=0.0081). Similar results were obtained using
reversine (Fig. 2.9b). I confirmed these results at a single-cell level, by following
mCherry-Mis12-Mad1 metaphase cells after inhibitor addition, using live imaging (Fig.
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2.9c-p). By 70 minutes after the Mps1-IN-1 wash-in, ~50% of the mCherry-Mis12-Mad1
cells that were initially at metaphase entered anaphase (Fig. 2.9o). Similarly, ~50% of
the metaphase mCherry-Mis12-Mad1 cells entered anaphase ~75 minutes after
reversine wash-in (Fig. 2.9p). Importantly, no lagging chromosomes were seen in the
anaphase cells, either in the live- or fixed-cell experiments with either Mps1 inhibitor,
supporting our observations that chromosomes are properly bioriented in the presence
of mCherry-Mis12-Mad1. These results indicate that cytosolic activities of Mps1 are
essential for maintaining checkpoint arrest, even when bioriented chromosomes are
present.
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Figure 2.9 Inhibition of Mps1 is sufficient for entry into anaphase, even when Mad1
persists at kinetochores. (a-b) Analysis of mitotic index and phenotypes in HeLa
(control), mCherry-Mis12-Mad1- and mCherry-Mis12-Mad1 AA- transfected cells upon
Mps1 inhibition. Cells were incubated in DMSO, Mps1-IN-1 (10 μM, 80 min) (a) or
reversine (500 nM, 120 min) before fixation (b). mCherry, tubulin and DNA staining was
used to calculate mitotic index and fraction of cells in metaphase, anaphase and all
other mitotic states (n= 3 independent experiments, > 350 cells counted per condition
per time). (c-p) Analysis of the effects of inhibition of Mps1 in live mCherry-Mis12Mad1-transfected cells. Metaphase mCherry-positive cells were selected before the
medium was changed to one containing DMSO, Mps1-IN-1 (10 μM) or reversine (500
nM; n= 3 independent experiments, > 10 cells per condition per experiment). Each of
those cells was imaged by multi-point re-visiting using microscope software. DIC (c, d, g,
h, k, l) and mCherry-fluorescence (e, f, i, j, m, n) images at the indicated times before
and after Mps1-IN-1 or reversine wash-in are shown. (o, p) Cumulative frequency of the
imaged cells entering anaphase after Mps-IN-1 (o) or reversine (p) wash-in. Scale bar, 5
μm. Average ± s.e.m. shown.
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Next, I examined the role of Aurora B kinase in directly maintaining checkpoint
arrest, independently of its upstream functions in kinetochore assembly and error
correction (Meraldi et al., 2004b). I incubated mCherry-Mis12-Mad1-transfected cells in
the Aurora B small-molecule inhibitor ZM447439 (Ditchfield et al., 2003). The mCherryMis12-Mad1 population showed a significant reduction in its mitotic index (Fig. 2.10a;
two-tailed T-test, p=0.016) and in the percentage of metaphase cells (two-tailed T-test,
p=0.0069) and, more importantly, a significant increase in the percentage of anaphase
cells (two-tailed T-test, p=0.018). The intensity of the mCherry-Mis12-Mad1 signals was
not reduced in the segregating chromosomes, ruling out the possibility that Aurora
inhibition merely removed the construct from the bioriented kinetochores (data not
shown). Similar results were obtained when I inhibited Aurora B with a different
inhibitor (hesperadin; Hauf et al., 2003; Fig. 2.10b, g-j, l). I confirmed these results at a
single-cell level with live imaging: 80 minutes after the addition of ZM447439 or
hesperadin, ~50% of the mCherry-Mis12-Mad1 cells that were initially at metaphase
transitioned to anaphase (Fig. 2.10c- l). Lagging chromosomes during anaphase were not
observed in our experiments, with either of the two inhibitors. These results
corroborate our fixed-cell analyses that inhibition of Aurora B activity is sufficient for
overriding the checkpoint, despite retention of Mad1 on kinetochores (Fig. 2.10f, j). A
recent study has shown that constitutive kinetochore localization of Mps1 also results in
a persistent mitotic arrest, but that inhibition of Aurora activity does not induce
anaphase entry in this case (Jelluma et al. 2010). This can be explained by the fact that
Mps1 force-localized at bioriented kinetochores may access substrates that, under
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normal conditions or in the presence of the Mis12-Mad1 fusion, it would not. Together
with these data, our findings suggest that Mps1 must be released from kinetochores for
Aurora inhibition to exert its anaphase-promoting effect. Further, our data indicate that
Aurora B activity is needed for maintenance of checkpoint arrest in human cells,
independently of its functions in kinetochore-protein recruitment and in biorientation.
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Figure 2.10 Inhibition of Aurora B is sufficient for entry into anaphase, even when
Mad1 persists at kinetochores. (a-b) Analysis of mitotic index and phenotypes in HeLa
(control), mCherry-Mis12-Mad1- and mCherry-Mis12-Mad1 AA- transfected cells upon
Aurora B inhibition. Cells were incubated in DMSO, ZM447439 (2 μM, 60 min) (a) or
hesperadin (50 nM, 90 min) before fixation (b). mCherry, tubulin and DNA staining was
used to calculate mitotic index and fraction of cells in metaphase, anaphase and all
other mitotic states (n= 3 independent experiments, > 350 cells counted per condition
per time). (c-l) Analysis of the effects of inhibition of Aurora B in live mCherry-Mis12Mad1-transfected cells. Metaphase mCherry-positive cells were selected before the
medium was changed to one containing DMSO, ZM447439 (2 μM) or hesperadin (50
nM; n= 3 independent experiments, > 10 cells per condition per experiment). Each of
those cells was imaged by multi-point re-visiting using microscope software. DIC (c, d, g,
h) and mCherry-fluorescence (e, f, i, j) images at the indicated times before and after
ZM447439 or hesperadin wash-in are shown. (k, l) Cumulative frequency of the imaged
cells entering anaphase after ZM447439 (k) or hesperadin (l) wash-in. Scale bar, 5 μm.
Average ± s.e.m. shown.
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Conclusions and discussion
In this Chapter, I showed that the recruitment of Mad1 and Mad2 to kinetochores via
the fusion of Mad1 to Mis12 is sufficient for the establishment of a checkpoint arrest,
regardless of chromosome biorientation. On the contrary, recruitment of Mad1 to nonkinetochore chromosomal locations via the fusion to CENP-B or H2B did not elicit a
checkpoint arrest independently of the status of microtubule attachment. In other
words, the kinetochore recruitment of Mad1 and Mad2 is sufficient for checkpoint
arrest, but whether this recruitment is also necessary is still unclear (further discussed in
Chapter 4). Using the Mis12-Mad1 construct to uncouple checkpoint signaling from
chromosome biorientation, I was able to assay the requirement for kinase activity in the
maintenance of checkpoint arrest independently of their “upstream”, indirectly
necessary functions. I showed that Mps1 and Aurora B activities are bona fide
checkpoint signaling components downstream of Mad1 and Mad2 kinetochore
recruitment.
The spindle assembly checkpoint must maintain anaphase inhibition until
biorientation of every chromosome is achieved. This requires the continuous generation
of the “wait” signal at levels such that even one mal-oriented kinetochore can block
progression (Rieder et al., 1994; Musacchio and Salmon, 2007). The Mad2-template
model of checkpoint signaling provides an attractive framework for how Mad1 and
Mad2 can detect the primary error and continuously produce the biochemical
anaphase-inhibitory signal, even when those proteins do not have canonical enzymatic
activities (Luo and Yu, 2008; Simonetta et al., 2009). Nevertheless, several kinases,
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which as enzymes can phosphorylate multiple substrate molecules to generate a
biochemically amplifiable signal, are believed to play a crucial role in the checkpoint
(Burke and Stukenberg, 2008; Kang and Yu, 2009). However, examining their
contribution to checkpoint establishment and maintenance had been difficult, especially
because many of these kinases have essential functions in preceding steps needed for
successful mitosis. This is particularly relevant for Aurora B kinase. It has been proposed
that inhibition of Aurora leads to checkpoint silencing indirectly, due to the consequent
stabilization of all improper attachments, which leads to the removal of Mad1-Mad2
from the kinetochores and hence to suppression of the primary error signal (Ditchfield
et al., 2003; Hauf et al., 2003; Pinsky et al., 2006). Nevertheless, experiments involving
Aurora inhibition together with the use of microtubule poisons suggest that Aurora is
directly required for maintaining mitotic arrest (Ditchfield et al., 2003; Hauf et al., 2003;
Emanuele et al., 2008; Kallio et al., 2002; Petersen and Hagan, 2003; Vanoosthuyse and
Hardwick, 2009). The override of the arrest seen there has been difficult to interpret
because prolonged arrest in high concentrations of Aurora inhibitors may disrupt
kinetochore assembly (Emanuele et al., 2008) and may also accumulate chemical
inhibitor’s off-target effects in vertebrates. Therefore, dissecting the contributions of
key cell cycle kinases (e.g. Aurora B) has remained challenging.
Using our constitutively-kinetochore-localized Mad1 assays, I was able to show in
human cells that Aurora activity is directly required for the maintenance of checkpoint
arrest. While it is difficult to rule out more complex models, I favor the hypothesis that
Aurora kinase is acting downstream of Mad1-Mad2 recruitment. Together with findings
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from others (Lan and Cleveland, 2010; Santaguida et al. 2011), our data suggest a model
in which the APC/C-inhibitory signal is maintained not only by Mad2-templated
dynamics, but also by Aurora kinase and cytosolic Mps1. Because in our assays cells
arrest in mitosis with bioriented chromosomes, our results suggest that this signaling
pathway is likely independent of mechanisms requiring the spatial separation of
kinetochore substrates from centromeric Aurora (Liu et al., 2009). Finding the relevant
molecular links between Aurora, Mps1 and the APC/C is an important next step. I
speculate that the MCC, the APC/C, p31/Comet and other poorly characterized
checkpoint silencing factors might be the relevant substrates. In fact, Mps1
phosphorylation sites on C-Mad2 necessary for checkpoint arrest maintenance have
recently been found (Zich et al. 2012). However, based on how challenging it has been
to find physiologically relevant mitotic kinase substrates, I anticipate that finding the
complete set of substrates will be a substantial undertaking. It is likely that our
constitutive kinetochore-localized Mad1 assay will be useful for these analyses.
It has recently been shown in vitro that chromosomes are not only required to
generate the APC/C-inhibitory signal, but are also capable of catalyzing its production
(Kulukian et al., 2009). Together with these data, our findings that recruitment of Mad1Mad2 to the kinetochore– but not throughout chromosomes– is needed to induce
mitotic arrest, suggest a model in which the local kinetochore environment is crucial for
generating the signal that will block anaphase when even a single chromosome remains
non-bioriented. Advances in high-resolution microscopy have built on a large body of
genetic and biochemical data to reveal the kinetochore architecture at nanometer
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resolution (Wan et al., 2009). Going forward, it will be important to dissect how the local
protein chemistry at kinetochores contributes to generating the “wait-anaphase” signal.
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Chapter 3: Characterizing the
effects of ciliobrevin D— the first
specific, small-molecule dynein
inhibitor— in mitotic cells
Summary
Accurate chromosome segregation depends on proper spindle assembly, which allows
for biorientation of kinetochores and progression into anaphase (Musacchio and
Salmon, 2007). Proper spindle assembly and function depend on the activity of motor
and

non-motor

microtubule-associated

proteins

that

regulate

microtubule

polymerization and depolymerization dynamics, cross-linking of microtubules at the
poles and chromosome-microtubule interactions at the kinetochores (Wadsworth et al.,
2011). The minus-end-directed microtubule-based motor protein dynein, a member of
the AAA+ protein family (ATPases associated with a variety of cellular activities), has
activities both at the spindle poles and at the kinetochore-microtubule interface and
plays important roles in proper spindle assembly (Vaisberg et al., 1993; Merdes et al.,
1996; Erzberger and Berger, 2006). However, dynein’s functions remain incompletely
understood due to the paucity of robust molecular tools for its study. In particular, no
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specific cell-permeable, acute, small molecule inhibitors—which would help further
dissect the motor-protein’s roles in spindle assembly and checkpoint silencing—had
been described prior to the work by Firestone et al. (2012), to which I contributed as
detailed below.
In this Chapter, I present work on “ciliobrevin D”, the small molecule discovered
by Dr James Chen and colleagues (Stanford University) that is the first specific dynein
inhibitor. I characterize its effects on mitotic cells and I describe how, in agreement with
known dynein functions, ciliobrevin D reversibly disrupts spindle bipolarity and the
integrity of kinetochore-microtubule interactions. Using ciliobrevin D, I uncover a new
role of dynein in spindle morphogenesis: dynein is involved not only in the
establishment of bipolarity, but also in its maintenance. The ciliobrevin family of
compounds will be valuable tools in the study of dynein roles in other mitotic and
interphase investigations and may also guide the development of specific inhibitors of
other AAA+ family members involved in a myriad of cellular and clinically relevant
processes.

Introduction

Dynein structure, function and behaviour
Dynein is a molecular motor of the AAA+ ATPase family that couples ATP hydrolysis to
movement towards the minus end of microtubules (Hughes et al., 1995). There are
three main dynein subfamilies, whose members are involved in a variety of cellular
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mechanisms (Hook and Vallee, 2006). At the axoneme, axonemal dynein is involved in
coordinating the beating of flagella and cilia (King, 2012). Cytoplasmic dynein 2 carries
out retrograde (minus-end-directed) intraflagellar transport and is necessary for
axoneme biogenesis and Hedgehog signaling, among other roles (Blacque et al., 2008;
Pazour et al., 1998). Cytoplasmic dynein 1, the most abundant of dyneins, is present in
all microtubule-containing cells in the cytoplasm, cell cortex and kinetochores (Dujardin
and Vallee, 2002; Bader and Vaughan, 2010). Cytoplasmic dynein 1 is responsible for the
minus-end directed movement of a wide array of cargoes: proteins (e.g. the checkpoint
proteins Mad1, Mad2; Howell et al., 2001), mRNA (e.g. the embryonic factors bicoid,
gurken and oskar; Bullock et al., 2006) and vesicles (e.g. Golgi particles, endosomes,
synaptic vesicles; Hunt and Stephens, 2011). As such, it is involved in diverse processes
such as embryogenesis, cell migration, Golgi morphology, neural axon polarization,
nerve regeneration and mitosis, among others.
Functional cytoplasmic dynein 1 is a ~1.5 mega-Dalton multi-complex of proteins,
consisting of three homodimers of heavy, intermediate, intermediate light and light
chains, associated with essential regulatory non-catalytic partners such as dynactin, LIS1
and Bicaudal D. These partners regulate dynein activity, processivity and cargo binding,
and their inhibition or depletion can almost completely phenocopy loss of dynein itself
(Kardon and Vale, 2009; Vallee et al., 2012).
The heavy chain is dynein’s catalytic core. Each heavy chain polypeptide (> 500 kDa)
contains a motor domain comprised of a hexameric repeat of AAA domains, a long ~15
nm antiparallel coiled-coil “stalk” that links the motor to the microtubule binding
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domain, a short “buttress” antiparallel coiled-coil that supports the base of the stalk and
contributes to force generation, a “linker” that acts as the main force transducer and
moves position with the mechanochemical cycle and an unstructured N-terminal tail
that interacts with the light/intermediate dynein chains, accessory non-catalytic
partners and cargo (Fig. 3.1; Carter et al. 2011; Kon et al. 2012; Schmidt et al. 2012).
Biochemical and structural studies have shown that the first AAA domain is the main
ATP hydrolysis site, with domains AAA2-4 likely exerting regulatory and/or structural
roles (Kon et al., 2004; Schmidt et al., 2012). It is obvious that substantial allosteric
communication between the head and microtubule binding domain must occur in order
to couple the ATP cycle to changes in microtubule affinity, but the details of this process
are yet to be completely elucidated. Significant improvements in the characterization of
dynein’s stepping behaviour have been recently described (DeWitt et al. 2012; Qiu et al.
2012). It was observed that, contrary to most motor proteins, dynein does not undergo
a “hand-over-hand” movement but, instead, walks in a likely tension-dependent,
partially-stochastic, partially-coordinated “inchworm” fashion.
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Figure 3.1 Dynein structure and binding partners. (a) Domain structure of dynein heavy
chain. The color coding is retained in (b). (b) X-ray crystal structure of Dictyostelium
discoideum dynein heavy chain at 2.8 A resolution (Kon et al, 2012). Note that neither
the N-terminal tail nor the C-terminal sequences are present. (c) Schematic
representation of the dynein complex (heavy chains in grey, intermediate chains in
green, light intermediate chains in darker blue, light chains in lighter blue) and some of
its binding partners (dynactin in pink, RZZ in yellow).
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Owing in part to the technical challenges posed by its large size, dynein has been a
difficult protein to study. Despite recent advances in the structural and biophysical
characterization of its motor domain and stepping behaviour, dynein remains much less
well understood than other motor proteins such kinesins (the other main type of
microtubule-based motor proteins), both in vitro and in cellular contexts. Another
significant impediment to dynein studies has been the lack of a specific inhibitor that
could be used acutely at the relevant time-scales needed. Although the ATP analogue
erythro-9-[3-(2-hydroxynonyl)]adenine and the antioxidant nordihydroguaiaretic acid
have been previously reported to abrogate dynein function (Bouchard et al., 1981;
Arasaki et al., 2007), these compounds are non-specific, promiscuous enzyme
antagonists. As such, their off-target effects cannot be overlooked. Moreover, only one
specific inhibitor has been described for any other AAA+ family member (Chou et al.
2011). Therefore, the development of a specific small-molecule inhibitor of dynein
would provide a significant tool for the advancement of the field and may also aid in the
development of inhibitors for other types of AAA+ proteins.

History of the ciliobrevin project
Dr James Chen’s laboratory at Stanford University uses chemical biology tools to study
the Hedgehog pathway, a signaling cascade essential for embryogenesis and stem cell
maintenance (Jiang and Hui, 2008). Hedgehog signaling is intimately related to cilia,
where components of the pathway are regulated (Goetz and Anderson, 2010). As such,
dynein activity is essential for proper Hedgehog signaling, as it is involved in the
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necessary retrograde intraflagellar transport of the Hedgehog signaling complex.
Accordingly, mouse embryos that are mutant for dynein heavy chain exhibit short and
few cilia and have altered Hedgehog gene expression (Huangfu and Anderson, 2005).
One of the hits from a recent cell-based chemical screen for Hedgehog inhibitors in
the Chen laboratory (Hyman et. Al., 2009), the benzoyl dihydroquinazolinone compound
“HPI4”, gave indications that it might be a dynein inhibitor: it not only blocked the
Hedgehog pathway, but it also reduced the number and size of cilia and induced Gli2
plus-tip accumulation, as seen in the dynein mutants (Kim et al., 2009). Due to its effects
on cilia, HPI4 was renamed “ciliobrevin”. Dr Chen and Dr Kapoor initiated a
collaboration to examine whether cilibrevin’s target was in fact dynein and to
characterize the effects of this small molecule on dynein activity in vitro and during
mitosis.
After synthesizing and examining a series of benzoyl dihydroquinazolinone
analogues with different chlorine substitution patterns and oxidation states, Chenlaboratory members observed that the derivative lacking a 3-chloro substituent on the
benzoyl ring system (henceforth “compound 2”) exhibited significantly diminished
inhibitory activity in Hedgehog signaling and primary cilia formation assays. Compound
2 was thereafter used as a negative control for in vitro and cell biological assays. The
analogue with a 7-chloro substitution (henceforth “ciliobrevin D”) exhibited more
potent inhibitory activity in Hedgehog signaling and cilia formation and was thus used as
the potential dynein inhibitor in all subsequent experiments (Fig. 3.2; Firestone et al.,
2012).
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To examine the inhibitory activity of ciliobrevin D on dynein in vitro, colleagues in
the Kapoor and Chen laboratories carried out microtubule gliding assays with purified
bovine dynein and showed that ciliobrevin D, but not compound 2, reversibly and
significantly reduced the average velocity of this motor (Fig. 3.2d, e). Moreover, they
showed that ciliobrevin D is an ATP-competitive dynein inhibitor (Fig. 3.2f). Specificity
was shown by the fact that ciliobrevin D has no inhibitory effects on other ATPase motor
proteins such as kinesins, on other types of AAA+ ATPases such as p97 or Mcm2-7, on
actin cytoskeleton dynamics or on other signaling pathways such as MAPK and PI3K
kinase pathways (Fig. 3.2g; Firestone et al. 2012). To begin to examine ciliobrevin
activity in a cellular context, our colleagues in the Gelfand laboratory (Northwestern
University) examined the small molecule’s effect on the dynein-dependent melanosome
aggregation in Xenopus cells upon melatonin stimulation and showed that ciliobrevin D
(but not compound 2) reversibly and selectively inhibited this process (Firestone et al.
2012).
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Figure 3.2 Characterization of the effects of ciliobrevins in vitro. (a, b) Molecular
structures of ciliobrevin D (a) and compound 2 (b). (c-g) Figures have been adapted from
figures 1 and 3 of Firestone et al. 2012. (c) Cilliary effects on NIH3T3 cells after a 24-hour
incubation in a 30 µM dose of compound 2, ciliobrevin D or an equivalent amount of
DMSO. Staining for DNA (DAPI; blue) and the cilium protein ARL13b (green) is shown. (dg) Effects of ciliobrevins on recombinant or purified bovine dynein in vitro. (d)
Kymographs of fluorescently labeled microtubules sliding on coverslip-adhered purified
bovine dynein in the presence of 100 µM of ciliobrevin compounds are shown. (e)
Quantification of data from (d). Average from at least 56 microtubules ± s.e.m. shown.
Asterisk indicates P < 10-6. (f) Hanes–Woolf plot of recombinant rat dynein motor in the
presence of increasing concentrations of ciliobrevin D. (g) Effects of increasing
concentrations of ciliobrevin D, compound 2 or DMSO on the ATPase activities of
recombinant motor domains of rat cytoplasmic dynein, human kinesin-1 and human
kinesin-5. Average for two independent experiments ± s.d. is shown. Scale bar, 10 µm.
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With my colleagues having shown that ciliobrevin D is a specific and reversible
inhibitor of dynein activity both in vitro and in interphase cells, my contribution to the
project was to validate the small molecule’s effects in mitotic cells by examining
whether the phenotypes created agreed with phenotypes seen for other types of dynein
mitotic inhibition. An expectation was that ciliobrevin might also be a useful tool for the
study of the roles of dynein in checkpoint silencing and how dynein relates to other
silencing-related proteins such as the Mad2-inhibitor p31/Comet. For instance, we could
examine whether dynein inhibition enhances the Mis12-Mad1 checkpoint arrest or the
requirement for p31/Comet in checkpoint silencing, or whether p31/Comet- and
dynein-dependent silencing mechanisms are additive, synergistic, or redundant.

Dynein in mitosis
In mitosis, cytoplasmic dynein 1 (hereafter, dynein) localizes at kinetochores, at spindle
poles and at the cell cortex and has functions in spindle assembly, spindle positioning,
the regulation of kinetochore-microtubule interactions and the spindle assembly
checkpoint.
Dynein interacts with and transports the cross-linking protein NuMA towards the
microtubule minus ends. Hence, dynein has a crucial role in the spindle pole formation
and organization, gamma-tubulin recruitment and thus in the establishment of spindle
bipolarity (Merdes et al., 2000; Young et al., 2000). By acting on the cortical
microtubules that emanate towards the cortex of the cell, dynein also plays a role in
positioning the spindle within the cytoplasm (Moore et al., 2009; Grill and Hyman, 2005;
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Kiyomitsu and Cheeseman, 2012). Dynein is also present at unattached kinetochores, to
which it is recruited via the interaction of its non-catalytic partner p50 (a component of
dynactin) with the RZZ complex component ZW10 (Starr et al., 1998). There, dynein has
been proposed to participate in microtubule end-on attachment and to regulate the
stability of kinetochore-microtubule interactions and kinetochore orientation (Varma et
al., 2008). Dynein also removes checkpoint proteins such as Mad1 and Mad2 from
bioriented kinetochores and transports them towards the spindle poles. This “dynein
stripping” process is believed to contribute to checkpoint silencing and anaphase
progression (Howell et al., 2001; see introduction for further details). Checkpoint
silencing remains the least well understood step of checkpoint signaling; novel
molecular tools for its study would therefore have a big impact on the field.
These and other presumed mitotic functions of dynein have been described and
studied using cell-biological techniques such as the microinjection of antibodies, the
overexpression of dominant-negative binding partners or heavy-chain truncations, or
heavy chain RNA interference. These perturbations are crude, as their specificity,
acuteness and reversibility are sub-optimal. In fact, significant inconsistency and
controversy have arisen from the use of different techniques (Bader and Vaughan,
2010). It is thus that a specific, acute, reversible molecular tool such as a small-molecule
inhibitor would be useful for the reliable characterization of dynein’s functions during
mitosis.
In the next section, I characterize the effects of ciliobrevin D in mitosis. I show that,
in agreement with previously reported dynein functions, ciliobrevin D reversibly inhibits
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spindle assembly, spindle pole organization and focusing, as well as stable kinetochoremicrotubule interactions.

Results

Ciliobrevin disrupts spindle bipolarity in mammalian cells
As described above, dynein acts with the cross-linking protein NuMA to focus the minus
ends of microtubules and help establish the spindle poles. Inhibition of dynein activity
with anti-dynactin antibodies or the expression of dominant negative constructs thus
results in unfocused poles (Merdes et al., 2000; Gaetz and Kapoor, 2004). To determine
whether ciliobrevin D could recapitulate these phenotypes, I treated a metaphaseenriched population of NIH-3T3 cells with 50 µM of ciliobrevin D or the inactive
analogue (compound 2) for one hour and examined their mitotic structures by
immunofluorescence microscopy.

Treated cells exhibited abnormal (unfocused,

multipolar, or collapsed) mitotic spindles with disrupted gamma tubulin localization (Fig.
3.3a, d-f). Cells incubated with the non-cilia-disrupting analogue or vehicle alone
(DMSO) exhibited normal spindle morphologies (Fig. 3.3b-c). Similar ciliobrevin-induced
spindle defects were observed in HeLa and RPE-1 cells, although to a lesser extent (Fig.
3.3g-h).
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Figure 3.3 Ciliobrevin D disrupts spindle bipolarity and spindle pole organization. (a-g)
NIH3T3 (a-f) or HeLa (g) cells were incubated with 10 µM proteosome inhibitor MG132
for 90 min and subsequently cultured in a medium with both MG132 (10 µM) and either
an inactive ciliobrevin analogue (compound 2) (c) or ciliobrevin D (d-f) at a 50 µM dose
or an equivalent amount of DMSO (a), for 1 hour. Cells were fixed and stained for DNA,
α-tubulin, and γ-tubulin and the morphology of their spindles were scored as bipolar or
abnormal (multipolar, collapsed or unfocused) (a, g) n= 3 independent experiments, >
150 spindles counted for each condition. (b-f) Representative images of NIH3T3 treated
as above. (h) Dose-response curve for NIH-3T3, HeLa and RPE-1 cells exposed to
increasing concentrations of ciliobrevin D. For each concentration, cells were treated,
fixed and stained as above. Average ± s.e.m. shown. Scale bar, 5 µm.
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Dynein is also required for establishing stable kinetochore-microtubule attachments
(Varma et al., 2008). Accordingly, ciliobrevin D treatment disrupted the formation of
cold-stable microtubules (as explained in the previous Chapter, an indicator of proper
kinetochore-microtubule interactions) in both 3T3 and HeLa cells (Fig. 3.4).
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Figure 3.4 Ciliobrevin D disrupts proper cold-stable kinetochore-microtubule
interactions. (a-d) NIH-3T3 (a-d) or HeLa (d) cells were incubated with 10 µM
proteosome inhibitor MG132 for 90 min and subsequently cultured in a medium with
both MG132 (10 µM) and either an inactive ciliobrevin analogue (compound 2) (b) or
ciliobrevin D (c) at a 50 µM dose or an equivalent amount of DMSO (a) for 1 hour before
being incubated on ice for 10 min. Cells were then fixed and stained for DNA, α-tubulin,
γ-tubulin and the kinetochore marker CREST. Individual channels and an overlay of
CREST and α-tubulin are shown. Insets (selected optical sections) show individual coldstable microtubule-attached (a, b) or unattached kinetochores (c) (4-fold magnification).
(d) Quantification of the effects of DMSO, compound 2 or ciliobrevin D on NIH3T3 and
HeLa cells treated as above. Average ± s.e.m. shown. Scale bar, 5 µm.
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Ciliobrevin does not affect dynein localization
To investigate if these spindle-disruptive effects were associated with altered
localization of dynein, I examined the targeting of key binding partners that recruit or
co-localize with this motor at different intracellular sites.

p150 Glued is the main

component of the dynein essential non-catalytic partner dynactin, and it tightly
interacts with dynein’s intermediate chain throughout mitosis (Holzbaur et al., 1991;
Kardon and Vale, 2009). Dynactin recruits dynein to kinetochores and spindle poles
during mitosis; moreover, disruption of p150Glued function mimics loss of dynein activity
(Starr et al., 1998; King et al., 2003; Schroer, 2004). Therefore, I analyzed the subcellular
localization of p150Glued in the presence of ciliobrevin D. Immunofluorescence analysis
showed that p150Glued localized to the disorganized spindle poles of metaphasearrested, ciliobrevin D-treated cells (Fig. 3.5).
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Figure 3.5 Ciliobrevin D does not affect the localization of p150Glued at spindle poles.
(a-e) NIH-3T3 cells were incubated with 10 µM proteosome inhibitor MG132 for 90 min
and subsequently cultured in a medium with both MG132 (10 µM) and either or
ciliobrevin D (b-e) at a 50 µM dose or an equivalent amount of DMSO (a). Cells were
then fixed and stained for DNA, α-tubulin, and p150Glued. Individual channels and an
overlay of CREST and α-tubulin are shown. Scale bar, 5 µm.

83

I then analyzed the targeting of p150Glued to kinetochores. Because kinetochore
recruitment of p150Glued and dynein depends on microtubule-attachment status, I
treated the cells with the microtubule poison nocodazole, to be able to disregard effects
due to differences in attachment. To ensure that ciliobrevin treatment does not disrupt
outer kinetochore structure, I also analyzed the localization of two outer kinetochore
proteins under the same conditions. These proteins were ZW10 (the component of the
RZZ complex that recruits dynein to kinetochores by interacting with the dynactin
component p50; Starr et al., 1998), and the kinetochore-associated kinesin-like protein
Centromere protein E (CENP-E; Yen et al., 1991). Quantitative analysis showed that
p150Glued, ZW10, and CENP-E were localized to outer kinetochores at comparable levels
to control cells, indicating that recruitment of these proteins and kinetochore structure
itself are not disrupted by the ciliobrevins (Fig. 3.6). These results suggest that dynein is
properly recruited to kinetochores and spindle poles in ciliobrevin-treated cells and that
the spindle phenotypes result from loss of dynein motor activity.

84

Figure 3.6 Quantitative analysis of ciliobrevin effects on protein localization at
unattached kinetochores. (a-f) NIH-3T3 cells were treated with the designated
compounds (at 50 µM) or an equivalent amount of DMSO for 45 min before addition of
1 μg/mL nocodazole (and either ciliobrevins or DMSO) for another 45 min. The cells
were then fixed and stained with CREST, p150 Glued, and either ZW10 (b, d) or CENP-E (c,
e). Fluorescence intensities at individual kinetochores were quantified. Data shown
here represent the intensity distributions of 2-4 independent experiments, with each
experiment involving the analysis of 4-7 cells and 10-15 kinetochores per cell per
condition (120-390 kinetochores per condition). (a-c) Histograms show the distribution
of signal intensities of p150Glued (a), ZW10 (b), and CENP-E (c) in cells treated as above.
(d,e) Representative images of cells treated and quantified as described above.
Numbers

associated

with

individual

micrographs

represent

the

average

immunofluorescence intensity of the respective protein at the analyzed kinetochores in
each image, relative to the overall average signal observed in DMSO-treated cells. Scale
bar, 5 μm.
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Ciliobrevin’s effects are reversible and its use reveals dynein’s role in the
maintenance of bipolarity
To further characterize the mitotic defects associated with ciliobrevin treatment, I
established a GFP-tubulin-expressing NIH-3T3 stable cell line and used it for real-time
confocal microscopy (Fig. 3.7 and 3.8). Severe defects were observed within minutes of
ciliobrevin D treatment: spindles appeared collapsed, bipolarity was lost, spindle poles
appeared disorganized and cells arrested in mitosis (Fig. 3.7b). Upon relief of inhibition,
bipolar spindles rapidly re-emerged and chromosomes were segregated at anaphase
(Fig. 3.7c-d). Interestingly, upon ciliobrevin D wash-out, a minority of cells (~5%) went
through a transient multipolar stage, after which the supernumerary poles were
coalesced and bipolarity was recovered, in accordance with dynein’s roles in pole
focusing (Fig. 3.7d). No pronounced defects in chromosome segregation were apparent
in either class of cells.
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Figure 3.7 Ciliobrevin D’s effects on mitotic spindles are fast and reversible. (a-d) The
media of asynchronous populations of NIH-3T3 cells stably expressing GFP-tubulin were
exchanged for medium containing Ciliobrevin D or DMSO. Prophase cells were identified
and time-lapse images were acquired. (a, b) Representative images of cells after the
addition of 50 μM ciliobrevin D (b) or an equivalent amount of DMSO (a). (c, d)
Representative images of the cells after the addition of 50 μM ciliobrevin D followed by
removal of the compound (“wash-out”). Examples show the recovery of bipolar spindle
morphology, which may involve pole re-focusing of supernumerary poles (d, arrows).
Times (min) relative to compound addition (a, b), or compound wash-out (c, d) are
shown. Scale bar, 5 μm.
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I next examined the effects of ciliobrevin exposure on pre-formed spindles of
metaphase-arrested cells. Again, I observed several defects in spindle size and shape
and pole fragmentation within minutes of ciliobrevin D addition (Fig. 3.8a-d). The livecell recordings also suggested that ciliobrevin D treatment caused a four-fold reduction
in overall microtubule levels in dividing cells (Fig. 3.8e). Although the inactive compound
2 also caused a two-fold reduction of tubulin fluorescence, spindle defects were not
observed. Importantly, I found that microtubule levels in non-dividing cells were
unaffected by inhibitor treatment (Fig. 3.8f-g), indicating that the ciliobrevins are not
tubulin poisons and that these effects are mitosis-specific. I then examined the recovery
of these disrupted spindles after ciliobrevin removal. Within minutes after wash-out,
microtubule levels recovered and supernumerary poles in multipolar spindles coalesced
to re-establish bipolarity (Fig. 3.8c-d), highlighting dynein’s role in pole focusing.
Together these data are consistent with ciliobrevin D inhibiting dynein’s functions in
pole organization and focusing. Because these spindle-disrupting effects are seen in cells
that were already bipolar at the start of the experiment, these data reveal a hitherto
under-appreciated requirement for dynein activity in the maintenance of spindle
bipolarity (as opposed to its mere establishment).
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Figure 3.8 Ciliobrevin D’s effects on metaphase-arrested and interphase cells. (a-e)
NIH-3T3 cells stably expressing GFP-tubulin were arrested in metaphase with MG132
(10 μM) and subsequently treated with DMSO (a) or 30 μM of either compound 2 (b) or
ciliobrevin D (c, d). The compounds were later washed out at the indicated time. Timelapse images were acquired at the indicated times (min relative to the initial MG132
treatment). Representative examples of ciliobrevin D-treated cells show recovery of the
spindle into a bipolar morphology after severe pole disruption (c) or severe microtubule
depolymerization (d). (e) Quantification of GFP-tubulin intensities of images
corresponding to the indicated times, relative to the initial intensity for each condition.
Average of 2-3 cells is shown. (f, g) Ciliobrevin D does not disrupt the interphase
microtubule network. NIH-3T3 cells stably expressing GFP-tubulin that were in
interphase were incubated in 30 μM ciliobrevin D or an equivalent amount of DMSO for
30 min before the compounds were washed out. Post-wash-out images were acquired
after 15 min and compared to images acquired 15 min before wash-in. (f) Histogram
depicting the ratio of microtubule intensities after and before washout of the relevant
compound, as gauged by GFP intensity (n= 2 independent experiments, >10 cells per
condition). Average ± s.e.m. shown (g) Representative images of the cells quantified
above and their individual pre-washout/post-washout ratios. Scale bars, (a-d) 5 μm; (g)
10 μm.
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Conclusions and discussion
In this Chapter, I examined the effects of ciliobrevin D on mitotic cells, in a collaborative
effort to characterize this molecule as the first specific small-molecule inhibitor of the
motor protein dynein. I showed that, as expected from previously published studies of
dynein inhibition with cruder molecular biology tools, ciliobrevin D reversibly causes a
severe disruption to pre-formed spindles, precludes de novo spindle assembly and
disrupts proper kinetochore-microtubule interactions in human and murine cells. The
use of ciliobrevin D on metaphase-arrested cells revealed that dynein is involved not
only on spindle bipolarity formation, but also in its maintenance. The data shown here,
together with the work of collaborators in the Kapoor, Gelfand, O’Donnell and Chen
laboratories, validate ciliobrevin D as the first specific, reversible, ATP-competitive
small-molecule antagonist of the AAA+ ATPase minus-end-directed motor protein
dynein (Firestone et al. 2012).
My work also reveals the limitations of ciliobrevin D in mitotic research: because it
inhibits both pole- and kinetochore-localized dynein, causing severe spindle disruption
and thus activating the spindle assembly checkpoint, its use in checkpoint silencing
studies is precluded. In order to be able to use a dynein inhibitor for such studies, the
molecule would need to inhibit the kinetochore-localized dynein only (i.e. not the
dynein molecules at the poles). Further chemical derivation and structure-activityrelationship studies could feasibly lead to the discovery of dynein isoform-selective
ciliobrevins (i.e. to distinguish cytoplasmic dynein 1 from 2). However, given that both
kinetochore- and pole-associated cytoplasmic dynein are both type 1, the generation of
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a kinetochore-specific ciliobrevin will likely be extremely challenging, if at all possible.
This is because, although we do not yet know what the binding site for ciliobrevin D on
dynein’s motor domain is, the fact that it is ATP-competitive suggests it is likely to bind
at or near the active site—which is the same for all cytoplasmic dynein 1 molecules,
regardless of their intracellular localization. Nevertheless, it is possible that the binding
to different recruiting partners that leads to dynein’s differential localization is
regulated by post-translational modifications on dynein’s polypeptides. If so, and if
those modifications induced structural changes to the ciliobrevin binding site, it may be
possible to discover kinetochore-specific dynein 1 ciliobrevin inhibitors. However, this
remains, in my opinion, unlikely. A more feasible approach might be to screen for
molecules that abrogate dynein’s interaction with the kinetochore recruiting factor, i.e.
molecules that disturb the p50–ZW10 interaction, in analogous fashion to previously
used dominant-negative strategies. However, shortcomings would include the need to
undertake an entirely new chemical screen and to overcome the challenges involved in
using small molecules to impede protein-protein interaction (Arkin and Wells, 2004).
Notwithstanding this limitation for checkpoint silencing studies, the ciliobrevin
compounds represent an important new, specific tool for biochemical, biophysical,
structural, cellular and clinical studies of dynein and its associated processes. For
instance, ciliobrevins may be used to dissect the recently described relationship
between cilia and cell cycle progression at the G1/S transition (Li et al. 2011; Kim et al.
2011). Supporting this, anecdotal evidence from my own and my colleagues’ studies
with ciliobrevin D suggests the molecule inhibits mitotic entry (data not shown).
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Furthermore, given that ciliobrevins are the first class of Hedgehog signaling inhibitors
downstream of Smoothened, they are significant additional tools for Hedgehog research
and may also have clinical applications (in particular, ciliobrevins 7 and 8—not described
here—which affect cilia formation without inhibiting dynein activity, Firestone et al.
2012). Ciliobrevin D and derivatives may also be used in in vitro and crystallographic
studies to dissect the heretofore elusive details of dynein’s mechanochemical cycle.
What is more, ciliobrevin D will likely be useful in a variety of cellular studies of
interphase cells, such as research on Golgi architecture, endosome recycling, axonal
transport, neurodegeneration, as well as mRNA localization during embryonic
patterning. Lastly, ciliobrevins may also provide a privileged starting point for the
development of specific antagonists of the variety of other AAA+ family members, which
includes not only biologically interesting proteins, but also clinically relevant targets
such as the peroxisome proteins Pex1 and Pex6, hereditary spastic paraplegia-inducing
paraplegin and spastin, and the myc-mediator oncogenes TIP49a/b (Ogura and
Wilkinson, 2001).
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Chapter 4: Discussion and future
directions
Summary
In the previous Chapters, I examined different mechanisms that contribute to mitotic
regulation. In Chapter 2, I examined the effect of constitutive Mad1 localization to
different parts of the chromosome. Using a fusion protein of Mad1 and the kinetochore
protein Mis12, I showed that constitutive Mad1 localization at the kinetochore leads to
constitutive checkpoint arrest even after all chromosomes have bioriented. This finding
indicated that the localization of Mad1-Mad2 at the kinetochore is sufficient for the
establishment of checkpoint arrest. I also showed that ectopic localization of Mad1Mad2 to the chromosome “arm” by fusion of Mad1 to H2B, or to the centromere by
fusion of Mad1 to CENP-E, was not able to evoke checkpoint arrest, lending some
support to the notion that kinetochores are essential for checkpoint signaling. Being
able to uncouple checkpoint signaling from chromosome biorientation using the Mis12Mad1 fusion, I then showed that BubR1, Mps1 and Aurora B activities (but not those of
Polo) are necessary for the maintenance of checkpoint arrest, independently of the
status of chromosome biorientation. In Chapter 3, I examined the mitotic effects of
ciliobrevin D, work that contributed to the validation of the molecule as the first specific

95

small-molecule inhibitor of the motor protein dynein. I showed that dynein inhibition by
ciliobrevin D not only recapitulates previously reported mitotic roles of dynein, but also
reveals a new function for this motor protein in the maintenance of spindle bipolarity. I
also explained why the molecule is not useful for further examination of the roles of
dynein in the metaphase-to-anaphase transition. In this Chapter, I discuss further
implications of these results, as well as possible directions in which these results can be
taken to extend our knowledge of mitosis.

Future directions

The role of kinetochores in checkpoint signaling
In Chapter 2, I showed that constitutive Mad1 localization at kinetochores is sufficient to
induce checkpoint arrest, even if all chromosomes are bioriented. Following this, I
wanted to examine whether constitutive localization of Mad1 on other parts of the
chromosome would lead to the same result. Several lines of evidence suggest that
checkpoint activity can originate in the cytoplasm, suggesting that kinetochores are not
essential for checkpoint signaling (Windecker et al., 2009; Meraldi et al., 2004a).
Therefore, I reasoned that ectopic localization experiments should allow examination of
the role of kinetochores and determine whether they are necessary for checkpoint
signaling.
Contrary to that seen with the Mis12-Mad1 fusion protein, fusion of Mad1 to
neither H2B nor CENP-B led to checkpoint arrest. I took these data to support the notion
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that kinetochores are essential for checkpoint signaling. However, several questions
were left unanswered. Firstly, the fact that ectopic localization with those fusion
partners and with those specific linkers used did not result in checkpoint arrest does not
mean that all possible ectopic localization experiments would give the same result. In
other words, the negative results may have been due to the wrong choice of partners
or, more simply, to technical issues. Secondly, although I showed that H2B-Mad1
recruits Mad2 all along the chromosome, I did not examine whether that ectopically
recruited C-Mad2 was able to recruit and activate cytoplasmic O-Mad2 with rates
comparable to control values of Mad2 activation at the kinetochore. For instance, it is
possible that technical issues such as the length of the linker precluded Mad1-bound-CMad2 from catalytically amplifying O-Mad2 molecules in the cytoplasm, even though it
correctly bound Mad1 on the chromosome. This issue could be addressed with FRAP
experiments to examine Mad2’s dynamics, as has been done in vitro and for Mad2 at
the kinetochore (Howell et al., 2000; Shah et al., 2004; Howell et al., 2004; Vink et al.,
2006). Even with these control experiments, the notion that kinetochores are essential
for checkpoint signaling would remain underdetermined, as a specific configuration may
exist in which ectopic recruitment of Mad1-Mad2 may elicit checkpoint arrest. Different
strategies for ectopic localization may therefore prove more useful.
Alternatively, reduced kinetics for Mad2 activation at the chromosome arm may
indicate not a mere technical deficiency, but the fact that additional factors are needed
in the vicinity of the core tetramer to make O-Mad2 amenable for activation. For
instance, it has been shown that Mps1 activity is needed for the sustained recruitment
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of O-Mad2 to the kinetochore, and it has been speculated that this may be required to
antagonize cytoplasmic Mad2’s interactions with its inhibitor p31 (Hewitt et al., 2010).
This hypothesis could be tested by depleting p31/Comet in cells expressing H2B-Mad1
and observing whether checkpoint arrest can be established in that case. Additionally,
an ectopic recruitment strategy that not only mislocalizes Mad1-Mad2, but also
ectopically recruits other checkpoint pathway components close to the core tetramer
may also shed light on these issues. Such a strategy is further discussed in following
section and in the Appendix chapter.

Conditional recruitment of Mad1 to kinetochores or other chromosomal locations
The use of a Mis12 fusion to constitutively localize Mad1 at kinetochores was a
successful method to show that kinetochore Mad1 localization is sufficient to induce
checkpoint arrest independently of biorientation. A modification that would make this
approach useful for the examination of a variety of mitotic questions would be to make
Mad1’s interaction with Mis12—and, hence, Mad1-Mad2’s localization at kinetochores
and checkpoint arrest— not constitutive but conditional.
A system that synchronized cells at metaphase without the need for chemical
inhibitors with questionable off-target and secondary effects (e.g. the use of the
proteosome inhibitor MG132), or for the inhibition of other key mitotic enzymes, would
be a useful research tool for the study of post-anaphase processes. The conditional
recruitment and release of Mad1 to and from kinetochores might allow us to reliably
synchronize cells by arresting in them metaphase (owing to Mad1 kinetochore
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localization) and releasing into anaphase upon the removal of Mad1. This approach
makes the assumption that the release of the engineered Mad1-Mad2 from the
bioriented kinetochores would be sufficient to induce checkpoint silencing, analogously
to what happens in normal cells with dynein stripping— it must be noted, however, that
the importance of this mechanism is debatable. This uncertainty notwithstanding, such
a conditional system would not only be useful as a synchronization tool, but may also be
useful in studies of the inter-relationships between the different checkpoint silencing
mechanisms.
A conditional Mad1-recruitment system may be achieved by combining the idea of
the Mis12-Mad1 fusion with the rapamycin-dependent dimerization of FRB and FKBP
(Banaszynski et al., 2005). For instance, we could use a mCherry-Mis12-FRB and FKBPGFP-Mad1 combination to recruit Mad1 to kinetochores in a conditional fashion. The
components would need to be tested for localization, dimerization and release
depending on rapamycin presence, kinetics, non-alteration of kinetochore-microtubule
interactions, etc. A potential technical pitfall is that rapamycin wash-out is difficult to
achieve in cells. An alternative strategy may be to use a chemical biological system that
controls not protein localization, but stability. By fusing Mis12-Mad1 to the protein
FKBP(L106P, hereafter FKBP*), we could control stability of the protein (and, hence, the
establishment of and release from checkpoint arrest) with the small molecule Shield:
FKBP* acts as a degradation tag on its own, but its proteolysis is prevented in the
presence of this compound (Banaszynski et al., 2006). The FKBP*/Shield system has
been successfully used to control protein expression in vertebrate and insect cells, as
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well as in whole organisms, but it has not so far been used specifically in mitotic cells
(Armstrong and Goldberg, 2007; Herm-Gotz et al., 2007; Banaszynski et al., 2008).
Before using this approach, we would need to validate its use during mitosis. For further
explanation and discussion of these strategies, as well as for preliminary results, please
refer to the Appendix chapter.
The control of checkpoint arrest establishment and release independently of
chromosome biorientation need not be limited to manipulations of Mad1. It has
recently been shown that, the MCC being the most downstream effector of checkpoint
signaling, expression of a fusion of Mad2 and BubR1 (or of Mad2 and BubR1 that are
artificially dimerizable via leucine zippers) is sufficient to induce checkpoint arrest in
budding yeast (Lau and Murray, 2012). Expressing FRB-FKBP-dimerizable or
FKBP*/Shield-regulated versions of these proteins in human cells might be an
alternative mechanism for cell synchronization and the examination of post-anaphase
events. Given that these are the most downstream components of the systems, the
kinetics of onset and release might be faster than those achieved by the regulation of
Mad1 localization or stability. This strategy, of course, remains to be experimentally
tested.
Finally, it may be worth revisiting the question of whether it is possible to establish
checkpoint arrest from a non-kinetochore location. Achieving it would not only show
that kinetochores are not essential for the checkpoint, but it would also allow us to
tackle other fundamental questions about the SAC signaling pathway. For instance, it
would inform us on what the minimal components of the checkpoint are, which may
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lead to improved in vitro reconstitution assays and analyses. Moreover, if we knew how
to reconstitute checkpoint arrest from defined ectopic location, we would be able to
carry out quantitative studies of how the checkpoint stop-anaphase signal is amplified
from a single locus (analogously to signaling from a single non-bioriented kinetochore).
A system that might be amenable for this may be the lac–ISceI–tet cell line, which
contains a single stable integration of an array of lac operators, followed by an array of
tet operators (Soutoglou et al., 2007). This method would involve recruiting pairs of
checkpoint proteins (e.g. Mad1 and a kinase) fused to lacI or TetR respectively and
examining whether that recruitment could evoke checkpoint arrest (and release). This
method is further explained in the Appendix chapter. Similarly to the H2B and CENP-B
fusions described above, negative results will not necessarily indicate that the system is
not useful and that kinetochores are necessary for checkpoint signaling.

The role of kinase activity in checkpoint maintenance and silencing
In Chapter 2, I showed that Aurora B or Mps inhibition via small molecules is sufficient
to override the arrest caused by the expression of Mis12-Mad1. This indicates that
Aurora B and Mps1 activities are needed for the maintenance of checkpoint arrest,
independently of their roles in kinetochore assembly and checkpoint protein
recruitment. How does kinase inhibition elicit entry into anaphase? Kinases are opposed
by phosphatases. In the absence of sustained kinase activity, phosphatase activity tips
the equilibrium towards dephosphorylation of substrates. More importantly, what are
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the relevant Aurora and Mps1 substrates and sites? How are the kinase circuits interrelated? What are the relevant opposing phosphatase complexes?
Feasible kinase substrate candidates downstream of kinetochore recruitment are
the members of the MCC, the APC/C-cdc20 complex and other silencing players, such as
p31/Comet and dynein. In fact, a few phosphorylation events on MCC components have
been identified in different organisms. For instance, phosphorylation of Mad2 by Mps1,
of BubR1 by Aurora and of cdc20 by Bub1 have been shown to affect checkpoint arrest
and release (Tang et al., 2004; King et al., 2007; Shepperd et al. 2012). Interestingly,
both positive and negative effects on checkpoint arrest have been observed (Shepperd
et al. 2012). These results should be re-valued and evaluated in more detail in the light
of the updated models of direct kinase roles in checkpoint signaling.
Furthermore, my results that inhibition of either kinase is sufficient to override the
checkpoint are in line with evidence that Aurora B and Mps1 act in a common pathway
(Jelluma et al. 2010; Lan and Cleveland, 2010). Nevertheless, the fact this sufficient
inhibition occurs after biorientation has been achieved and Mps1 has been released to
the cytoplasm suggests that a more complex pathway may be in place. It is also very
likely that the checkpoint silencing circuit will include different types of motifs and
feedback loops. Therefore, it is paramount that the whole set of players and interactions
be identified. Identification of kinase/phosphatase substrates could be done, for
instance, using a combination of bioinformatics, chemical genetics, mass spectrometry
and high-throughput RNAi screens, to be later validated in cell biological experiments
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(e.g. Hegemann et al. 2011; Hengeveld et al. 2012; Oppermann et al. 2012). Our Mis12Mad1 construct may be of use in such screens and validation assays.
It will also be interesting to examine how the kinase/phosphatase circuits interact
with the other mechanisms of checkpoint silencing and what their relative contributions
are in a variety of different model organisms. For instance, does PP1 dephosphorylation
affect dynein stripping in higher eukaryotes? Could PP1-gamma be responsible for
activating p31/Comet? The fact that Aurora B or Mps1 inhibition is sufficient to override
checkpoint arrest in human cells suggests that they might be the most important
components of the system. Furthermore, the fact that Mad1-Mad2 remain at the
kinetochores of the segregating chromosomes supports the idea that dynein stripping
might play a merely accessory role in checkpoint silencing (this work and also Canman et
al., 2002). This is also in line with the fact that dynein is not necessary for mitosis of
lower eukaryotes. A dynein small molecule inhibitor that acted only at kinetochores
would have been a very useful tool to examine these questions in more detail.
Unfortunately, as discussed in Chapter 3, ciliobrevin D is not useful for these types of
experiments, as its inhibition of pole-localized dynein leads to the disruption of bipolar
spindles and the maintenance of checkpoint arrest. The development of a small
molecule that inhibited the interactions between dynein and ZW10 would be useful tool
in this regard.
Finally, could a better understanding of checkpoint silencing lead to the
development of better therapeutic strategies in cellular hyper-proliferative diseases
such as cancer? Preventing checkpoint silencing not only delays proliferation, but also
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increases the probabilities of death in mitosis (Janssen and Medema, 2011). As such, it
could provide alternative strategies and uncover new combination therapies that might
be effective.

Perspective
The field has come a long way since the initial identification of the first checkpoint
components in 1991 (Hoyt et al., 1991; Li and Murray, 1991). Nevertheless, several
unanswered question still remain. For instance, what is the precise architecture of the
kinetochore, before and after attachment? Although significant structural advances
have been made recently, we still do not fully grasp how the interactions between the
kinetochore and checkpoint components change upon biorientation. Are kinetochores
really essential for checkpoint activity per se, or is their role actually to couple
biorientation with silencing? Similarly, how does the structural change upon
biorientation translate into checkpoint silencing, especially in the cytoplasm? And what
do the details of checkpoint silencing differ in different organisms? Is silencing
complexity correlated with the rise of complexity in kinetochore structure, attachment
modes, and centromere specification?
Another important advance has been the recognition that checkpoint kinases do
indeed have a direct role in checkpoint signaling, and we are beginning to uncover how
their phosphorylations prevent cdc20 activity. Nevertheless, as mentioned above,
crucial details such as specific kinase substrates and their relevant sites, the possible
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inter-plays of different kinase loops and the relevant phosphatase regulation are still
unknown.
Moreover, unresolved issues still remain with the Mad2-template model. What is
the definitive answer on the question of C-Mad2 auto-catalytic amplification in the
cytoplasm? What is p31/Comet’s physiological contribution as a “brake”? How are
Mad1-C-Mad2 complexes in the cytoplasm regulated? How does SAC activity originate
in the cytoplasm independently of kinetochores, and is this a physiologically important
process, or is it just a minor component? Likewise, we need a much clearer
understanding of the amplification parameters and kinetics in cells and a more careful
examination of the notion that a single non-bioriented chromosome can establish as
robust an arrest as the full set of unattached kinetochores in metaphase.

Contributions of this thesis
In this thesis, I have contributed to the study of some fundamental questions of the
spindle assembly checkpoint mechanism. Is Mad1-Mad2 kinetochore localization
sufficient for checkpoint arrest? Is kinase activity necessary for checkpoint signaling per
se? Can we develop chemical tools for the study of checkpoint silencing? I have arrived
at some answers, but, invariably, more questions remain. Are kinetochores necessary
for checkpoint signaling? What are the kinase substrates relevant for checkpoint signal
maintenance? What is the circuit for checkpoint silencing?
Clearly, much more cellular, biochemical, structural and biophysical research
remains to be done in these and other areas to achieve a complete description of the
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complex workings of the spindle assembly checkpoint. I hope the findings and tools
described in this thesis will be of use for future investigation in these areas.
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Appendix: Towards a system for
conditional checkpoint signaling
independently of chromosome
biorientation
Summary
In the previous Chapters, I showed how constitutively kinetochore-localized Mad1 is
sufficient to induce spindle assembly checkpoint signaling independently of
chromosome biorientation. I discussed how it would be beneficial to have a conditional
system for Mad1 recruitment to the kinetochore or elsewhere on the chromosome that
would allow us not only to reliably synchronize and release cells at the metaphase-toanaphase transition, but also to investigate, among others, questions regarding the
need for kinetochores as signaling hubs, the minimal components sufficient for
checkpoint signaling and the mechanism of checkpoint signaling amplification. In this
Chapter, I describe preliminary efforts towards the development of such a system.
Firstly, I describe attempts to use a rapamycin-dependent dimerizer system of the
domains FRB and FKBP fused to Mis12 and Mad1, respectively. This approach proved
unsuccessful due to inappropriate expression levels of the fusion proteins involved.
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Secondly, I describe a related approach consisting on Shield-dependent rescue of an
FKBP(L106P)-Mis12-Mad1 fusion protein (hereafter, FKBP*-Mis12-Mad1). I was able to
validate the use of this approach in mitotic cells, and preliminary results indicate that
Shield-rescued FKBP*-Mis12-Mad1 does indeed induce metaphase arrest. Lastly, I
describe a system to conditionally recruit checkpoint components to ectopic locations
on the chromosome arm, by interaction of lac and tet repressors to their respective
DNA operators. This system, although promising, is still in the cloning stage. The full
development of these of other systems for a rapid, reversible and tunable induction of
checkpoint signaling independently of chromosome biorientation would be a significant
tool for the dissection of long-standing mitotic questions.

Conditional checkpoint signaling independently of chromosome biorientation

Rapamycin-dependent FRB-FKBP-mediated Mis12-Mad1 dimerization
The localization of Mad1 at the kinetochore is sufficient to induce checkpoint arrest
even when chromosomes are bioriented. I reasoned that if I could conditionally and
reversibly recruit Mad1 to kinetochores by an artificial heterodimerization method, I
may be able to conditionally establish and release a checkpoint-based metaphase arrest
independently of the checkpoint’s primary signal, i.e., I would have a reliable system for
arresting and releasing cells at the experimenter’s convenience, without the need for
inhibition of kinases or other mitotic proteins that might be under study.
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The first approach I took towards this was using a rapamycin-dependent FRB-FKBP
dimerization system. Rapamycin is a 31-membered macrolide small molecule that has
been of use in molecular biological studies due to its ability to simultaneously bind with
high affinity to the FRB domain of mTOR and to the protein FKBP, thereby inducing their
heterodimerization (Banaszynski et al., 2005). This feature has been exploited as a
research tool to heterodimerize proteins by fusing them to FRB and FKBP and it has
proven a successful strategy to control the spatio-temporal activation of a variety of
proteins. Moreover, the system has been successfully used in the Kapoor laboratory to
ectopically recruit the PP2A regulatory subunit R5B to the chromosome “arm”, by using
an H2B-FRB, FKBP-R5B system (Dr Lei Tan, Kapoor laboratory, personal communication).
Encouraged by this background, I decided to use the rapamycin- dependent FRBFKBP dimerization to conditionally localize Mad1 at the kinetochore by inducing its
dimerization with Mis12. To prevent the default localization of Mad1 to kinetochores, I
decided to use a truncation of Mad1 (Mad1F10) that lacks amino acids 1-320, which
encode Mad1’s kinetochore-localizing sequences (Canman et al., 2002). I produced a
FKBP-Mad1F10-GFP construct (Fig. A.1) and used it together with the previously
developed Mis12-mCherry-FRB construct (a gift from Dr Lei Tan, Kapoor laboratory).
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Figure A.1 Schematic representation of FRB-FKBP dimerization-mediated system for
microtubule-independent, conditional checkpoint arrest. (a) FRB and FKBP dimerize in
the presence of rapamycin and separate upon rapamycin removal. (b) Proposed system:
in cells expressing Mis12-FRB and FKBP-Mad1F10, the addition of rapamycin would
recruit Mad1F10 to kinetochores through the dimerization of FRB and FKBP, which
would lead to checkpoint arrest. Upon rapamycin removal, dimerization would be
abrogated, Mad1F10 would be released from kinetochores and the spindle assembly
checkpoint would be overridden (if Mad1-Mad2 removal from bioriented kinetochores
were sufficient for checkpoint silencing).
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I generated and examined stable cell lines or transient transfections in all possible
permutations of the components: I made a double stable cell line with both constructs,
stable cell lines with a single component to which I transiently transfected the other
one, or transiently transfected both elements under a variety of protocols. To examine
the dimerization dynamics of FKBP-Mad1F10 and FRB-Mis12, I performed near
simultaneous live-imaging for mCherry and GFP channels of metaphase-arrested cells
after the addition of 20 nM rapamycin. Under none of the conditions examined did I see
GFP signal at (Mad1F10 recruitment to) the kinetochores, even after incubation in 50
nM of rapamycin for over 6 hours (for comparison, PP2A R5B was 8-fold enriched after
15 min in 20 nM rapamycin, Dr Tan, personal communication). It is likely this is due to
either low expression levels of Mis12-FRB or low level of recruitment at the
kinetochores (also observed by Dr Tan). Moreover, GFP signal in the cytoplasm was
heterogeneous and mostly localized to cytoplasmic aggregations. In addition to these
setbacks, the fact that it would be difficult to wash rapamycin off to reverse the
dimerization prompted me to stop optimizing this system and focus on an alternative
strategy instead.

Shield1-dependent FKBP(L106P)-Mis12-Mad1 fusion protein level control
My second approach towards the development of a system for conditional checkpoint
arrest and release independent of the checkpoint’s primary signal was the FKBP*/Shield
system developed by Dr Wandless and colleagues (Banaszynski et al., 2006). They
developed a system for the control of protein levels by manipulating the degradation of
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a novel degron consisting of a FKBP mutant (L106P) with the rapamycin-derived small
molecule “Shield”. FKBP* remains semi-unfolded in the cytoplasm and is thus targeted
for degradation by the proteosome. If fused to a protein of interest, FKBP* will act as a
degradation tag for the fusion protein. In the presence of Shield, FKBP* can fold
properly and it thus “shielded” from its degradation. Dr Wandless’ group showed that
this system allows specific, rapid, reversible, tunable control of protein levels in
interphase cells (Fig. A.2a). The strategy has been successfully used with a variety of
proteins in cells and whole organisms (e.g. Banaszynski et al., 2008, Herm-Gotz et al.,
2007, Armstrong and Goldberg, 2007).
The system seemed applicable to regulate Mad1 at kinetochores by
manipulating protein levels of Mis12-Mad1 as opposed to manipulating Mad1
recruitment. Because all characterization of the FKBP*/Shield system had been done in
interphase cells, I first needed to validate the approach in single mitotic cells. In the
following sections, I describe my validation of the system in mitotic cells using FKBP*GFP and I then describe experiments using mCherry-FKBP*-Mis12-Mad1.
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Figure A.2 Schematic representation of FKBP*/Shield-mediated system for
microtubule-independent, conditional checkpoint arrest. (a) FKBP* is a degron that
targets fused proteins of interest (POI) for degradation. The small molecule Shield
allows the correct folding of FKBP* and prevents its degradation, thus rescuing
expression levels of the POI. (b) Proposed system: in cells expressing FKBP*-Mis12Mad1, the addition of Shield would rescue the expression of the fusion protein, which
would be recruited to kinetochores and, analogously to mCherry-Mis12-Mad1, lead to
checkpoint arrest. Upon Shield removal, FKBP*-Mis12-Mad1 would be degraded and the
spindle assembly checkpoint would be overridden (if Mad1-Mad2 removal from
bioriented kinetochores were sufficient for checkpoint silencing).
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Validation with FKBP*-GFP
To examine whether the FKBP*/Shield system can be used in mitotic cells and, if so,
whether it exhibits the same kinetics as in interphase cells, I fused FKBP* to GFP and
made stable FKBP*-GFP RPE-1 and HeLa cell lines. I arrested the cells in mitosis using the
microtubule depolymerizing drug nocodazole and followed the changes in GFP protein
levels by quantifying the fluorescence signals of the cells upon Shield wash-in (to
measure GFP “rescue”) or Shield wash-out (to measure GFP degradation).
Shield-dependent rescue and FKBP* degradation were observable at a single-cell
level in interphase and mitotic (nocodazole-arrested) cells. The kinetics of GFP rescue in
mitotic cells in the presence of 1 μM Shield reached a ~2-fold enrichment (relative to
starting levels) by 5 h (Fig. A.3 b, e). Published experiments show that FKBP* is rescued
to ~10% of its maximal level by 4 h interphase cells (Banaszynski et al., 2006). Because I
imaged cells for five to eight hours, I was not able to record the maximum rescue levels.
Nevertheless, taking the published data as reference, I would expect a ~20-fold
enrichment of FKBP* fusion protein levels by 24 h in the presence of Shield. Higher final
concentrations of Shield should also improve the extent of protein level rescue, but this
variable was not explored. The kinetics of FKBP*-mediated degradation of GFP were
similar to the rates seen for interphase NIH-3T3 cells for both interphase and mitotic
cells (Banaszynski et al., 2006): after 16 h-22 h exposure to 1 μM Shield, half-maximal
degradation was achieved in ~1 h in mitotic cells with quasi-first-order kinetics (Fig A.3 c,
d, f).
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Figure A.3 Shield-dependent regulation of GFP expression levels in RPE-1 cells. (a-f) A
stable retroviral RPE-1 cell line containing FKBP*-GFP was subjected to addition of 1 μM
Shield (a, b, e) or its removal after overnight incubation (c,d,f). Interphase (a, c) and
mitotic (b, d) cells were identified imaged in approximately hourly intervals (shown in
top right corner of each image). (e,f) GFP fluorescence levels were quantified for each
condition (3-8 cells per condition). Average ± s.d. shown. Scale bar, 10 µm.
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From these preliminary experiments I conclude that the FKBP*/Shield system
can be used to control protein levels in mitotic cells and that the changes in GFP levels in
mitosis are similar to those seen in interphase cells. In the next section, I describe how I
have started using this system to conditionally arrest and release cells in and out of
mitosis, independently of the checkpoint’s primary signal.
Experimentation with FKBP*-Mis12-Mad1
To regulate the levels of Mad1 present at the kinetochores, I decided to make the fusion
protein

mCherry-FKBP*-Mis12-Mad1.

Preliminary

experiments

using

transient

transfection showed that the fusion is rescued by Shield (1 μM), that the stabilized
fusion protein localizes at kinetochores and that it induces metaphase arrest in
agreement with data described in Chapter 2 for mCh-Mis12-Mad1 (Fig. A.4 and 2.3). In
fact, the mitotic index increase seen with a 24-hour rescue of mCherry-FKBP*-Mis12Mad1 (46%, 1 μM Shield, > 250 cells, 2 coverslips, 1 experiment) was higher than that
previously seen with 24-hour expression of mCherry-Mis12-Mad1 (27.6% ± 2%, n= 3
independent experiments, > 400 cells counted per condition per time; Fig. A.4 and 2.3).
Although these percentages may not be directly comparable, the strong metaphase
arrest seen with Shield rescue was certainly encouraging.
The

mCherry-FKBP*-Mis12-Mad1

fusion

protein

was

detectable

by

immunofluorescence but not by live imaging (presumably because expression level was
below fluorescence detection limit, as seen with other Mis12 constructs, Dr Tan,
personal communication). Hence, I decided to make a stable cell line, such that I could
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incubate the cells in medium with Shield for longer times. A HeLa mCherry-FKBP*Mis12-Mad1 stable cell line has been made and is ready for testing.

Figure A.4 Shield-dependent expression and kinetochore localization of mCherryFKBP*-Mis12-Mad1 in HeLa cells. (a, b) Twenty-four hours after transient transfection
with mCherry-FKBP*-Mis12-Mad1, HeLa cells were incubated in 1 µM Shield (b) or an
equivalent amount of ethanol (a). Twenty-four hours later, they were imaged live. No
mCherry signal was detectable for either population (not shown). Following these live
imaging experiments (i.e. after a ~ 28-hour incubation in Shield or ethanol), additional
equivalent coverslips were fixed and processed for immunofluorescence. Staining for
mCherry is shown, together with DIC image of these fixed cells. Scale bar, 10 µm.
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Lac-Tet repressor/operator system
The third approach to study checkpoint signaling independently of its primary signal that
I will describe is a system for conditionally recruiting Mad1 and other checkpoint
components to ectopic chromosomal locations, i.e. at a specific point on the
chromosome, away from the kinetochore. This system would allow us to investigate
long-standing questions on checkpoint signaling. For instance, can we reconstitute
checkpoint activity away from the kinetochore? If so, what are the minimal
requirements for checkpoint signaling? The system would also allow us to examine
checkpoint signal amplification and re-evaluate the long-standing belief that a single
non-bioriented chromosome is sufficient for checkpoint arrest in a more precise and
controlled manner.
The system that we envisioned for achieving this is a dual lac
operator/repressor- tet element/repressor system, based on reagents previously
developed by Dr Misteli (NIH; Soutoglou et al., 2007). These and similar systems have
been successfully used to recruit DNA damage proteins to an experimentally controlled
DNA double strand break, as well as for visualizing gene expression in real time and
following chromosome segregation patterns (Chubb et al., 2002, Janicki et al., 2004,
Bakhoum et al., 2009, Thompson and Compton, 2010). Dr Misteli’s system consists of a
NIH-3T3-derived cell line that contains a stable insertion of an array of lac operators
(lacO), followed by a ISceI restriction site, followed by an array of tetracycline responsive
elements (TRE) at a defined site on one chromosome (hereafter, the lac–ISceI–tet cell
line).
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We hypothesized that, if we made a derivation of the lac–ISceI–tet cell line that also
stably expressed fusion proteins of the lac-repressor (lacI) and tet-repressor (TetR) with
checkpoint proteins, we would be able to conditionally recruit checkpoint proteins to
the ectopic location to examine the questions on checkpoint signaling outlined above
(Fig. A.5).

Figure A.5 Schematic representation of lac and tet operator/repressor recruitmentmediated system for microtubule-independent, conditional checkpoint arrest from an
ectopic location. (a) The cells used in the proposed system contain a stable, noncentromeric, chromosomal insertion of an array of lac operators followed by an array of
tet responsive elements. The cells would also express fusion proteins of combinations of
checkpoint proteins (Mad1 and Mps1 depicted) fused to the lac and tet repressors,
respectively. (b) Upon the removal of IPTG and addition of doxycycline, the repressorfused checkpoint proteins would be recruited to the corresponding array, which may
lead to checkpoint arrest.
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We reasoned that we might be able to reconstitute checkpoint activity by combining
the ectopic recruitment of two different classes of checkpoint proteins: a structural,
detection protein (e.g. Mad1) and an amplification protein (e.g. a checkpoint kinase).
We decided to start with a combination of a TetR-Mad1 and Mps1-lacI. Experiments to
validate the approach are under way.
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Materials and methods
Cell lines, and plasmid and siRNA transfection
HeLa and NIH-3T3 cells were grown in Dulbecco's modified Eagle's medium (DMEM;
Invitrogen) and RPE-1 cells, in DMEM-F12 1:1 mixture (Invitrogen), supplemented with
10% fetal bovine serum (HeLa and RPE-1; Sigma) or 10% bovine calf serum (NIH-3T3;
Sigma), 2 mM L-Glutamine (Invitrogen), 1X non-essential amino acid solution
(Invitrogen) and penicillin–streptomycin (100 U ml-1 and 100 μg ml-1 respectively;
Invitrogen), at 37 °C in a humidified atmosphere with 5% CO2. Cells were plated on polyD-Lysine-coated (Sigma) glass coverslips (Fisher Scientific) in 6-well or 12-well dishes. All
stable cell lines were generated by retroviral infection with pMSCV-based plasmids with
the appropriate open reading frame (ORF) fused to the relevant fusion partner by
overlap PCR and cloned into GFP- or mCherry-tagged vectors by Gateway technology,
followed by selection with puromycin (Sigma), following suppliers’ and standard
protocols. The linker used between the Mis12, H2B or CENP-B(1-158) and Mad1 (or AA)
ORFs was: 5’- GGCGGTTCACGCGGCCGCTCAAGCTTGGGAGGCGGTAGT-3'.
All plasmid transfections were done with FuGENE HD (Roche Diagnostics),
following manufacturer’s instructions, 24 hours (unless otherwise specified) before
processing for immunofluorescence, live imaging or lysis for western blots. siRNA
transfections were performed by reverse transfection with Lipofectamine RNAiMax
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(Invitrogen) following manufacturer’s instructions,

24 hours before plasmid

transfection. siRNA duplexes against Mad2 (5'-AAGAGUCGGGACCACAGUUUA-3'), BubR1
(5'-AACGGGCATTTGAATATGAAA-3') and GFP (5'-GGCAAGCUGACCCUGAAGUUC-3') were
purchased from Dharmacon Research.

Antibodies
Antibodies used for immunofluorescence were: polyclonal antibodies against mCherry
(1: 500; custom-generated and validated by L. Tan, Kapoor laboratory, by immunization
of rabbits with recombinant GST-tagged full-length mCherry at Cocalico Biologicals and
subsequent serum affinity purification using a HiTrap NHS activated column, GE
Healthcare Life Sciences; antibody directly conjugated to Dy-light 549 from Thermo
Scientific was used for CENP-E co-localization experiments), CENP-E (HX-1; 1: 2000; a gift
from T. Yen, Fox Chase Cancer Center, Philadelphia, PA), ZW10 (1: 1000; abcam), antigamma-tubulin (1:500 dilution, Sigma-Aldrich, T6557); monoclonal antibodies against tubulin (DM1A, FITC-conjugated; 1: 6000 Sigma-Aldrich, F2168), Mad1 (9B10; 1: 500;
Santa Cruz Biotechnology), p150Glued (1: 1000; BD Transduction Laboratories), Bub1 (1:
1000; abcam) and ROD (43-K; 1: 100; Santa Cruz); human CREST anti-serum (1: 20000; a
gift from W. Brinkley, Baylor College of Medicine, Houston, TX). Secondary antibodies
conjugated to fluoroscein isothyocyante (FITC), Dylight-549, DyLight 649- or Cy5 were
from Jackson ImmunoResearch (1:400). The same mCherry (1: 1000) and anti-Mad1 (1:
500) antibodies were used for western blots, following standard procedures. Secondary
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antibodies were IRDye 800CW from Li-Cor Biosciences. Blots were detected using the
Odyssey Infrared Imaging System (Li-Cor).

Immunofluorescence microscopy
For all immunofluorescence experiments, cells were pre-extracted with 100 mM K-Pipes
at pH 6.9, 4 M Glycerol, 1 mM EGTA, 5 mM MgCl2 and 0.5% Triton X-100 at 37 °C for 90
s and then fixed with 3.7% formaldehyde in 100 mM PIPES at pH 6.9, 10 mM EGTA, 1
mM MgCl2and 0.2% Triton X-100 at room temperature (or on ice, for cold-treatment
experiments) for 10 min. Cells were blocked with 2% bovine serum albumin and 0.1%
Triton-X in TBS for 15 min. Antibodies were diluted in the same medium. DNA was
stained with Hoechst 33342 (Sigma).
Images were acquired as Z-stacks with 0.2 μm spacing using a 100×, 1.35 NA
objective on a DeltaVision Image Restoration Microscope (Applied Precision Instruments
and Olympus) and processed by iterative constrained deconvolution (SoftWoRx, Applied
Precision Instruments). Images shown are maximal intensity projections of the Z-stacks
that were cropped and processed using ImageJ (NIH). Magnified optical sections (insets)
show individual kinetochores more clearly. Image analysis was performed using
SoftWoRx or ImageJ (NIH) software.
For chromosome spreads, cells were arrested in nocodazole (1 μg ml-1) for 60 min,
harvested by trypsinization, incubated in 0.0075 M KCl for 30 min and spun in a cytospin
at 1000 r.p.m. for 1 min before processing for immunofluorescence as above.
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Small-molecule inhibition treatments
For microtubule depolymerization, cells were incubated in 1 μg ml-1 nocodazole at 37 °C
for 45 min before fixation. For cold treatment, cells were incubated with 10 μM MG132
for 2 h and then incubated in ice-cold L-15 medium (Invitrogen) on ice for 10 min before
fixation. For inhibition of Aurora B activity, before fixation, cells were incubated in 50
nM hesperadin for 90 min, 2 μM ZM447439 for 60 min, or equivalent amounts of DMSO
for the respective intervals, at 37 °C. For inhibition of Mps1 activity, cells were incubated
in 10 μM Mps1-IN-1 (a kind gift from N. Gray, Harvard Medical School, Boston, MA) or
500 nM reversine (Cayman Chemicals) for 2 hours. For Plk-1 inhibition, cells were
incubated in 80 nM BI2536 for 90 min before fixation. For all instances were cells were
counted, DNA (stained with Hoechst stain) and spindle morphology were used to
determine cell cycle stage.
For analysis of the effects on ciliobrevin compounds on the spindle, cells were
incubated in medium containing 10 µM MG132 for 90 min. The medium was then
exchanged with DMEM containing 0.5% (v/v) calf serum, 10 µM MG132, and either 50
µM of the indicated benzoyl dihydroquinazolinones or an equivalent amount of the
DMSO vehicle, and the cells were cultured for an additional 60 min at 37 °C. For coldtreatment experiments, the cells were incubated on ice, and the medium was
exchanged with ice-cold DMEM containing 0.5% (v/v) calf serum, 10 µM MG132, and
either 50 µM of the indicated compounds or an equivalent amount of the DMSO
vehicle.
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To examine the localization of p150Glued, ZW10, and CENP-E, NIH-3T3 cells were
incubated for 45 min with DMEM containing 0.5% fetal bovine serum and either 50 µM
ciliobrevin D, 50 µM analog 2, or an equivalent amount of DMSO. The cells were then
incubated in medium that also contained 1 µg/mL nocodazole (and the respective
compounds/DMSO) for another 45 min. The cells were fixed as above.
p150Glued localization in cells with intact microtubules was also examined by
culturing NIH-3T3 cells in DMEM containing 10% fetal bovine serum and 10 µM MG132
for 90 min. The medium was then exchanged with DMEM containing 0.5% (v/v) fetal
bovine serum, 10 µM MG132, and 50 µM ciliobrevin D or an equivalent amount of
DMSO. The cells were then fixed and processed for immunostaining as above. The antip150Glued and CREST antibodies were incubated overnight at 4 °C; all other antibodies
were incubated for 1 hour at room temperature.

Live imaging
Cells were grown on 22 mm × 22 mm glass coverslips (Fisher Scientific) coated with polyD-lysine (Sigma) and imaged one day or two days after transfection (with mCherryMis12-Mad1 or mCh-H2B-Mad1, respectively), by mounting in Rose chambers and using
L-15 medium without phenol-red (Invitrogen), at 35–37 °C. Images were acquired using
a Nikon TE2000 confocal microscope equipped using a Plan Apochromat 100X/1.4 NA
oil-immersion objective and a PerkinElmer Wallac UltraView confocal head, an argon ion
laser (Solamere) and Metamorph software (Universal Imaging). GFP and mCherry
fluorescences were obtained with 488-nm and 568-nm excitation filters, respectively.
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Confocal stacks were acquired with 0.5 μm spacing. Images were analyzed and
processed with either Metamorph or ImageJ software. Images shown are maximal
projections of the Z-stacks.
For Aurora B inhibition experiments, hesperadin or DMSO were washed into the
chamber by exchanging the L-15 medium (10% fetal bovine serum) with the compounds
at the aforementioned concentrations. For live-imaging studies of ciliobrevin effects
wash-in experiments of mitotic cells were conducted by adding L-15 medium containing
0.5% fetal bovine serum and either 50 µM ciliobrevin D or an equivalent amount of
DMSO. In washout experiments, the compound or solvent vehicle was removed by
exchanging the medium twice with L-15 containing 10% FBS. To study the effects of
ciliobrevins on MG132-arrested cells, the GFP-tubulin-expressing cells were incubated in
L-15 medium containing 10% fetal bovine serum and 10 µM MG132. Thirty minutes
later, the medium was exchanged to L-15 with 0.5% fetal bovine serum, 10 µM MG132,
and either 30 uM of the indicated compounds or an equivalent amount of DMSO. Fifty
minutes after the wash-in, the compounds were washed out by exchanging the medium
twice with L-15 containing 10% fetal bovine serum and 10 µM MG132.

Fluorescence-signal quantification
To quantify interphase microtubule intensities, the GFP-tubulin-expressing NIH-3T3 cells
were incubated with L-15 medium containing 0.5% fetal bovine serum and either 30 µM
ciliobrevin D or an equivalent amount of DMSO for 15 min. Interphase cells were
identified by DIC microscopy, and an 8- to 12-plane Z-stack (0.2 µm step size)
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encompassing the network of cytoplasmic microtubules was acquired for the GFP
channel. For ciliobrevin D experiments, a mitotic cell was imaged before the interphase
cells, to ensure microtubule depolymerization had occurred. Ciliobrevin D or DMSO was
washed out by exchanging the medium twice with L-15 containing 10% fetal bovine
serum 35-50 min after the initial addition of compound or solvent vehicle. The cells
were then re-visited and imaged as before, approximately 15 min after the wash-out (at
which time the microtubule density of the imaged mitotic cells had recovered). To
quantify microtubule intensity in individual cells before and after ciliobrevin/DMSO
wash-out, planes of the Z-stack that showed maximal microtubule intensity were
summed, and GFP intensity was measured for a region of interest in the cell cytoplasmic
and in a nearby background area of the same size. The background-corrected intensity
was calculated as (GFP-tubulin fluorescence – background fluorescence)/background
fluorescence, and the corresponding ratio of post- and pre-wash-out intensities was
calculated for each cell.
To quantify intensity of mCherry, p150Glued, ZW10 or CENP-E signal at individual
kinetochores, CREST signal from deconvolved Z-stacks was used to identify individual
kinetochores. A region of interest (ROI) was drawn at the corresponding position for the
mCherry channel, at the identified planes, and the integrated density of the sum of the
ROIs was calculated. To account for background fluorescence, the corrected
fluorescence was calculated as in ref.15: briefly, by measuring the fluorescence of a
slightly larger box and scaling the “inner” fluorescence to the ratio of the areas. The
same treatment was done for the corresponding CREST staining, and the corrected
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mCherry fluorescence was normalized to the corrected CREST fluorescence. An
analogous method was used to measure the mCherry or GFP fluorescence of whole cells
or spindles, after the summation of fluorescence of individual planes of a Z-stack
acquired by live imaging.

Appendix methods

Rapamycin-dependent, FRB-FKBP-mediated Mis12-Mad1 dimerization
The pMSCV Mis12-mCherry-FRB construct was a gift from Dr Lei Tan (Kapoor
laboratory). The pMSCV FKBP-Mad1F10-GFP construct was produced by PCR overlap
cloning, followed by Gateway cloning, using standard or manufacturer’s procedures.
HeLa stable cell lines of either construct or both constructs together were produced by
retroviral infection, followed by selection with puromycin (and subsequently
hygromycin, for the double cell line). For the single cell lines, the remaining construct
was transiently transfected using Fugene HD (Roche Diagnostics). Subsequent
treatments were carried out 24 or 48 hours after transfection (both options were
examined fully in different experiments). To examine dimerization of FKBP-Mad1F10GFP and Mis12-mCherry-FRB, cells were arrested in metaphase with 10 µM MG132 for
30 min and metaphase cells were localized and imaged live with GFP and mCherry
channels to obtain respective Z-stacks. The medium was then exchanged to one
containing 10 µM MG132 and 20 nM rapamycin and the cells were re-visited and
imaged at 30 min intervals for over 5 hours.
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Shield1-dependent FKBP*-Mis12-Mad1 fusion protein level control
The pMSCV FKBP*-GFP and mCherry-FKBP*-Mis12-Mad1 constructs were produced by
PCR overlap cloning, followed by Gateway cloning, using standard or manufacturer’s
procedures. The original FKBP* plasmid was a gift from Dr Matthew Pratt (USC). HeLa
and RPE-1 stable cell lines of the GFP construct were produced by retroviral infection,
followed by selection with puromycin. For mCherry-FKBP*-Mis12-Mad1, HeLa cells were
transiently transfected using Fugene HD; subsequent treatments were done 24 hours
after transfection. To examine the kinetics of Shield-dependent rescue of FKBP*-GFP or
mCherry-FKBP*-Mis12-Mad1, cells were arrested in mitosis by incubation with 1ug/ml
nocodazole for 30-45 min, and mitotic and interphase cells were localized and imaged
live with DIC and GFP channels. The medium was then exchanged to one containing
1ug/ml nocodazole and 1 µM Shield (Clontech; or an equivalent amount of ethanol, as
control) and the cells were re-visited and imaged at hourly intervals for 5 hours. To
examine the kinetics of FKBP*-GFP degradation upon Shield removal, cells were
incubated in 1 µM Shield for 16 or 22 hours, they were then incubated in a medium
containing 1 µM Shield and 1ug/ml nocodazole for 1 hour, at which point mitotic and
interphase cells were localized and imaged live with DIC and GFP channels. After this
initial imaging, the medium was exchanged to one containing only 1 µM Shield and the
cells were re-visited and imaged at hourly intervals for 7 hours. Fluorescence intensity of
GFP rescue or degradation was measured by calculating the intensity of GFP in the
whole cell and then corrected for background as described above.

129

Bibliography
Abrieu, A., Magnaghi-Jaulin, L., Kahana, J.A., Peter, M., Castro, A., Vigneron, S., Lorca, T.,
Cleveland, D.W., and Labbe, J.C. (2001). Mps1 is a kinetochore-associated kinase
essential for the vertebrate mitotic checkpoint. Cell 106, 83-93.
Arasaki, K., Tani, K., Yoshimori, T., Stephens, D.J., and Tagaya, M. (2007).
Nordihydroguaiaretic acid affects multiple dynein-dynactin functions in
interphase and mitotic cells. Mol Pharmacol 71, 454-460.
Arkin, M.R., and Wells, J.A. (2004). Small-molecule inhibitors of protein-protein
interactions: progressing towards the dream. Nat Rev Drug Discov 3, 301-317.
Armstrong, C.M., and Goldberg, D.E. (2007). An FKBP destabilization domain modulates
protein levels in Plasmodium falciparum. Nat Methods 4, 1007-1009.
Bader, J.R., and Vaughan, K.T. (2010). Dynein at the kinetochore: Timing, Interactions
and Functions. Semin Cell Dev Biol 21, 269-275.
Bakhoum, S.F., Thompson, S.L., Manning, A.L., and Compton, D.A. (2009). Genome
stability is ensured by temporal control of kinetochore-microtubule dynamics. Nat
Cell Biol 11, 27-35.
Banaszynski, L.A., Chen, L.C., Maynard-Smith, L.A., Ooi, A.G., and Wandless, T.J. (2006).
A rapid, reversible, and tunable method to regulate protein function in living cells
using synthetic small molecules. Cell 126, 995-1004.
Banaszynski, L.A., Liu, C.W., and Wandless, T.J. (2005). Characterization of the
FKBP.rapamycin.FRB ternary complex. J Am Chem Soc 127, 4715-4721.
Banaszynski, L.A., Sellmyer, M.A., Contag, C.H., Wandless, T.J., and Thorne, S.H. (2008).
Chemical control of protein stability and function in living mice. Nat Med 14,
1123-1127.
Barford, D. (2012). Structural insights into anaphase-promoting complex function and
mechanism. Philos Trans R Soc Lond B Biol Sci 366, 3605-3624.
Barnhart, E.L., Dorer, R.K., Murray, A.W., and Schuyler, S.C. (2011). Reduced Mad2
expression keeps relaxed kinetochores from arresting budding yeast in mitosis.
Mol Biol Cell 22, 2448-2457.
130

Blacque, O.E., Cevik, S., and Kaplan, O.I. (2008). Intraflagellar transport: from molecular
characterisation to mechanism. Front Biosci 13, 2633-2652.
Bouchard, P., Penningroth, S.M., Cheung, A., Gagnon, C., and Bardin, C.W. (1981).
erythro-9-[3-(2-Hydroxynonyl)]adenine is an inhibitor of sperm motility that
blocks dynein ATPase and protein carboxylmethylase activities. Proc Natl Acad Sci
U S A 78, 1033-1036.
Bullock, S.L., Nicol, A., Gross, S.P., and Zicha, D. (2006). Guidance of bidirectional motor
complexes by mRNA cargoes through control of dynein number and activity. Curr
Biol 16, 1447-1452.
Burke, D.J., and Stukenberg, P.T. (2008). Linking kinetochore-microtubule binding to the
spindle checkpoint. Developmental Cell 14, 474-479.
Canman, J.C., Sharma, N., Straight, A., Shannon, K.B., Fang, G., and Salmon, E.D. (2002).
Anaphase onset does not require the microtubule-dependent depletion of
kinetochore and centromere-binding proteins. J Cell Sci 115, 3787-3795.
Carter, A.P., Cho, C., Jin, L., and Vale, R.D. (2011). Crystal structure of the dynein motor
domain. Science 331, 1159-1165.
Chao, W.C., Kulkarni, K., Zhang, Z., Kong, E.H., and Barford, D. (2012). Structure of the
mitotic checkpoint complex. Nature 484, 208-213.
Cheeseman, I.M., and Desai, A. (2008). Molecular architecture of the kinetochoremicrotubule interface. Nat Rev Mol Cell Biol 9, 33-46.
Cheeseman, I.M., Niessen, S., Anderson, S., Hyndman, F., Yates, J.R., 3rd, Oegema, K.,
and Desai, A. (2004). A conserved protein network controls assembly of the outer
kinetochore and its ability to sustain tension. Genes Dev 18, 2255-2268.
Chen, R.H., Waters, J.C., Salmon, E.D., and Murray, A.W. (1996). Association of spindle
assembly checkpoint component XMAD2 with unattached kinetochores. Science
274, 242-246.
Chen, R.H., Shevchenko, A., Mann, M., and Murray, A.W. (1998). Spindle checkpoint
protein Xmad1 recruits Xmad2 to unattached kinetochores. J Cell Biol 143, 283295.
Chen, R.H., Brady, D.M., Smith, D., Murray, A.W., and Hardwick, K.G. (1999). The spindle
checkpoint of budding yeast depends on a tight complex between the Mad1 and
Mad2 proteins. Mol Biol Cell 10, 2607-2618.

131

Chou, T.F., Brown, S.J., Minond, D., Nordin, B.E., Li, K., Jones, A.C., Chase, P., Porubsky,
P.R., Stoltz, B.M., Schoenen, F.J., et al. (2011). Reversible inhibitor of p97, DBeQ,
impairs both ubiquitin-dependent and autophagic protein clearance pathways.
Proc Natl Acad Sci U S A 108, 4834-4839.
Chubb, J.R., Boyle, S., Perry, P., and Bickmore, W.A. (2002). Chromatin motion is
constrained by association with nuclear compartments in human cells. Curr Biol
12, 439-445.
Chung, E., and Chen, R.H. (2002). Spindle checkpoint requires Mad1-bound and Mad1free Mad2. Mol Biol Cell 13, 1501-1511.
De Antoni, A., Pearson, C.G., Cimini, D., Canman, J.C., Sala, V., Nezi, L., Mapelli, M.,
Sironi, L., Faretta, M., Salmon, E.D., et al. (2005). The Mad1/Mad2 complex as a
template for Mad2 activation in the spindle assembly checkpoint. Curr Biol 15,
214-225.
DeLuca, J.G., Howell, B.J., Canman, J.C., Hickey, J.M., Fang, G., and Salmon, E.D. (2003).
Nuf2 and Hec1 are required for retention of the checkpoint proteins Mad1 and
Mad2 to kinetochores. Curr Biol 13, 2103-2109.
DeLuca, J.G., and Musacchio, A. (2012). Structural organization of the kinetochoremicrotubule interface. Curr Opin Cell Biol 24, 48-56.
DeWitt, M.A., Chang, A.Y., Combs, P.A., and Yildiz, A. (2012). Cytoplasmic dynein moves
through uncoordinated stepping of the AAA+ ring domains. Science 335, 221-225.
Ditchfield, C., Johnson, V.L., Tighe, A., Ellston, R., Haworth, C., Johnson, T., Mortlock, A.,
Keen, N., and Taylor, S.S. (2003). Aurora B couples chromosome alignment with
anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J Cell Biol 161,
267-280.
Dujardin, D.L., and Vallee, R.B. (2002). Dynein at the cortex. Curr Opin Cell Biol 14, 4449.
Emanuele, M.J., Lan, W., Jwa, M., Miller, S.A., Chan, C.S., and Stukenberg, P.T. (2008).
Aurora B kinase and protein phosphatase 1 have opposing roles in modulating
kinetochore assembly. J Cell Biol 181, 241-254.
Erzberger, J.P., and Berger, J.M. (2006). Evolutionary relationships and structural
mechanisms of AAA+ proteins. Annu Rev Biophys Biomol Struct 35, 93-114.
Fang, G. (2002). Checkpoint protein BubR1 acts synergistically with Mad2 to inhibit
anaphase-promoting complex. Mol Biol Cell 13, 755-766.
132

Faulkner, N.E., Dujardin, D.L., Tai, C.Y., Vaughan, K.T., O'Connell, C.B., Wang, Y., and
Vallee, R.B. (2000). A role for the lissencephaly gene LIS1 in mitosis and
cytoplasmic dynein function. Nat Cell Biol 2, 784-791.
Firestone, A.J., Weinger, J.S., Maldonado, M., Barlan, K., Langston, L.D., O'Donnell, M.,
Gelfand, V.I., Kapoor, T.M., and Chen, J.K. (2012). Small-molecule inhibitors of the
AAA+ ATPase motor cytoplasmic dynein. Nature 484, 125-129.
Gaetz, J., and Kapoor, T.M. (2004). Dynein/dynactin regulate metaphase spindle length
by targeting depolymerizing activities to spindle poles. J Cell Biol 166, 465-471.
Goetz, S.C., and Anderson, K.V. (2010). The primary cilium: a signaling centre during
vertebrate development. Nat Rev Genet 11, 331-344.
Gorbsky, G.J., Sammak, P.J., and Borisy, G.G. (1987). Chromosomes move poleward in
anaphase along stationary microtubules that coordinately disassemble from their
kinetochore ends. J Cell Biol 104, 9-18.
Griffis, E.R., Stuurman, N., and Vale, R.D. (2007). Spindly, a novel protein essential for
silencing the spindle assembly checkpoint, recruits dynein to the kinetochore. J
Cell Biol 177, 1005-1015.
Grill, S.W., and Hyman, A.A. (2005). Spindle positioning by cortical pulling forces. Dev
Cell 8, 461-465.
Hardwick, K.G., Johnston, R.C., Smith, D.L., and Murray, A.W. (2000). MAD3 encodes a
novel component of the spindle checkpoint which interacts with Bub3p, Cdc20p,
and Mad2p. J Cell Biol 148, 871-882.
Hardwick, K.G., and Murray, A.W. (1995). Mad1p, a phosphoprotein component of the
spindle assembly checkpoint in budding yeast. J Cell Biol 131, 709-720.
Hardwick, K.G., Weiss, E., Luca, F.C., Winey, M., and Murray, A.W. (1996). Activation of
the budding yeast spindle assembly checkpoint without mitotic spindle
disruption. Science 273, 953-956.
Hartwell, L.H., and Weinert, T.A. (1989). Checkpoints: controls that ensure the order of
cell cycle events. Science 246, 629-634.
Hauf, S., Cole, R.W., LaTerra, S., Zimmer, C., Schnapp, G., Walter, R., Heckel, A., van
Meel, J., Rieder, C.L., and Peters, J.M. (2003). The small molecule Hesperadin
reveals a role for Aurora B in correcting kinetochore-microtubule attachment and
in maintaining the spindle assembly checkpoint. J Cell Biol 161, 281-294.

133

Hegemann, B., Hutchins, J.R., Hudecz, O., Novatchkova, M., Rameseder, J., Sykora,
M.M., Liu, S., Mazanek, M., Lenart, P., Heriche, J.K., et al. (2011). Systematic
phosphorylation analysis of human mitotic protein complexes. Sci Signal 4, rs12.
Hengeveld, R.C., Hertz, N.T., Vromans, M.J., Zhang, C., Burlingame, A.L., Shokat, K.M.,
and Lens, S.M. (2012). Development of a chemical genetic approach for human
aurora B kinase identifies novel substrates of the chromosomal passenger
complex. Mol Cell Proteomics 11, 47-59.
Herm-Gotz, A., Agop-Nersesian, C., Munter, S., Grimley, J.S., Wandless, T.J.,
Frischknecht, F., and Meissner, M. (2007). Rapid control of protein level in the
apicomplexan Toxoplasma gondii. Nat Methods 4, 1003-1005.
Hoffman, D.B., Pearson, C.G., Yen, T.J., Howell, B.J., and Salmon, E.D. (2001).
Microtubule-dependent changes in assembly of microtubule motor proteins and
mitotic spindle checkpoint proteins at PtK1 kinetochores. Mol Biol Cell 12, 19952009.
Holland, A.J., and Cleveland, D.W. (2012). Losing balance: the origin and impact of
aneuploidy in cancer. EMBO Rep 13, 501-514.
Holzbaur, E.L., Hammarback, J.A., Paschal, B.M., Kravit, N.G., Pfister, K.K., and Vallee,
R.B. (1991). Homology of a 150K cytoplasmic dynein-associated polypeptide with
the Drosophila gene Glued. Nature 351, 579-583.
Hook, P., and Vallee, R.B. (2006). The dynein family at a glance. J Cell Sci 119, 43694371.
Howell, B.J., Hoffman, D.B., Fang, G., Murray, A.W., and Salmon, E.D. (2000).
Visualization of Mad2 dynamics at kinetochores, along spindle fibers, and at
spindle poles in living cells. J Cell Biol 150, 1233-1250.
Howell, B.J., McEwen, B.F., Canman, J.C., Hoffman, D.B., Farrar, E.M., Rieder, C.L., and
Salmon, E.D. (2001). Cytoplasmic dynein/dynactin drives kinetochore protein
transport to the spindle poles and has a role in mitotic spindle checkpoint
inactivation. J Cell Biol 155, 1159-1172.
Howell, B.J., Moree, B., Farrar, E.M., Stewart, S., Fang, G., and Salmon, E.D. (2004).
Spindle checkpoint protein dynamics at kinetochores in living cells. Curr Biol 14,
953-964.
Hoyt, M.A., Totis, L., and Roberts, B.T. (1991). S. cerevisiae genes required for cell cycle
arrest in response to loss of microtubule function. Cell 66, 507-517.

134

Huangfu, D., and Anderson, K.V. (2005). Cilia and Hedgehog responsiveness in the
mouse. Proc Natl Acad Sci U S A 102, 11325-11330.
Hughes, S.M., Vaughan, K.T., Herskovits, J.S., and Vallee, R.B. (1995). Molecular analysis
of a cytoplasmic dynein light intermediate chain reveals homology to a family of
ATPases. J Cell Sci 108 ( Pt 1), 17-24.
Hunt, S.D., and Stephens, D.J. The role of motor proteins in endosomal sorting. Biochem
Soc Trans 39, 1179-1184.
Hunt, T., Nasmyth, K., and Novak, B. The cell cycle. Philos Trans R Soc Lond B Biol Sci
366, 3494-3497.
Hyman, J. M., Firestone, A. J., Heine, V. M., Zhao, Y., Ocasio, C. A., Han, K., Sun, M., Rack,
P. G., Sinha, S., Wu, et. al. (2009). Small-molecule inhibitors reveal multiple
strategies for Hedgehog pathway blockade. Proc Natl Acad Sci U S A 106, 14132-7.
Inoue, M., Arasaki, K., Ueda, A., Aoki, T., and Tagaya, M. (2008). N-terminal region of
ZW10 serves not only as a determinant for localization but also as a link with
dynein function. Genes Cells 13, 905-914.
Iouk, T., Kerscher, O., Scott, R.J., Basrai, M.A., and Wozniak, R.W. (2002). The yeast
nuclear pore complex functionally interacts with components of the spindle
assembly checkpoint. J Cell Biol 159, 807-819.
Janicki, S.M., Tsukamoto, T., Salghetti, S.E., Tansey, W.P., Sachidanandam, R., Prasanth,
K.V., Ried, T., Shav-Tal, Y., Bertrand, E., Singer, R.H., et al. (2004). From silencing
to gene expression: real-time analysis in single cells. Cell 116, 683-698.
Janke, C., Ortiz, J., Lechner J., Shevchenko A., Shevchenko A., Magiera A.M., Schramm C.
and Schiebel E. (2001). The budding yeast proteins Spc24p and Spc25p interact
with Ndc80p and Nuf2p at the kinetochore and are important for kinetochore
clustering and checkpoint control. EMBO J 20, 777 – 791.
Janssen, A., Medema, R.H. (2011). Mitosis as an anti-cancer target. Oncogene 30, 27992809.
Jelluma, N., Dansen, T.B., Sliedrecht, T., Kwiatkowski, N.P., and Kops, G.J. (2010).
Release of Mps1 from kinetochores is crucial for timely anaphase onset. J Cell Biol
191, 281-290.
Jiang, J., and Hui, C.C. (2008). Hedgehog signaling in development and cancer. Dev Cell
15, 801-812.

135

Kallio, M.J., McCleland, M.L., Stukenberg, P.T., and Gorbsky, G.J. (2002). Inhibition of
aurora B kinase blocks chromosome segregation, overrides the spindle
checkpoint, and perturbs microtubule dynamics in mitosis. Curr Biol 12, 900-905.
Kang, J., Yang, M., Li, B., Qi, W., Zhang, C., Shokat, K.M., Tomchick, D.R., Machius, M.,
and Yu, H. (2008). Structure and substrate recruitment of the human spindle
checkpoint kinase Bub1. Mol Cell 32, 394-405.
Kang, J., and Yu, H. (2009). Kinase signaling in the spindle checkpoint. J Biol Chem 284,
15359-15363.
Kardon, J.R., and Vale, R.D. (2009). Regulators of the cytoplasmic dynein motor. Nat Rev
Mol Cell Biol 10, 854-865.
Karess, R. (2005). Rod-ZW10-Zwilch: a key player in the spindle checkpoint. Trends Cell
Biol 15, 386-392.
Kim, J., Kato, M., and Beachy, P.A. (2009). Gli2 trafficking links Hedgehog-dependent
activation of Smoothened in the primary cilium to transcriptional activation in the
nucleus. Proc Natl Acad Sci U S A 106, 21666-21671.
Kim, S., Zaghloul, N.A., Bubenshchikova, E., Oh, E.C., Rankin, S., Katsanis, N., Obara, T.,
and Tsiokas, L. (2011). Nde1-mediated inhibition of ciliogenesis affects cell cycle
re-entry. Nat Cell Biol 13, 351-360.
King, E.M., Rachidi, N., Morrice, N., Hardwick, K.G., and Stark, M.J. (2007). Ipl1pdependent phosphorylation of Mad3p is required for the spindle checkpoint
response to lack of tension at kinetochores. Genes Dev 21, 1163-1168.
King, S.J., Brown, C.L., Maier, K.C., Quintyne, N.J., and Schroer, T.A. (2003). Analysis of
the dynein-dynactin interaction in vitro and in vivo. Mol Biol Cell 14, 5089-5097.
King, S.M. (2012). Integrated control of axonemal dynein AAA(+) motors. J Struct Biol.
Kiyomitsu, T., and Cheeseman, I.M. (2012). Chromosome- and spindle-pole-derived
signals generate an intrinsic code for spindle position and orientation. Nat Cell
Biol 14, 311-317.
Kline, S.L., Cheeseman, I.M., Hori, T., Fukagawa, T., & Desai, A. (2006). The human Mis
12 complex is required for kinetochore assembly and proper chromosome
segregation. J Cell Biol 173, 9-17.

136

Kon, T., Nishiura, M., Ohkura, R., Toyoshima, Y.Y., and Sutoh, K. (2004). Distinct
functions of nucleotide-binding/hydrolysis sites in the four AAA modules of
cytoplasmic dynein. Biochemistry 43, 11266-11274.
Kon, T., Oyama, T., Shimo-Kon, R., Imamula, K., Shima, T., Sutoh, K., and Kurisu, G.
(2012). The 2.8 A crystal structure of the dynein motor domain. Nature 484, 345350.
Koshland, D.E., Mitchison, T.J., and Kirschner, M.W. (1988). Polewards chromosome
movement driven by microtubule depolymerization in vitro. Nature 331, 499-504.
Kulukian, A., Han, J.S., and Cleveland, D.W. (2009). Unattached kinetochores catalyze
production of an anaphase inhibitor that requires a Mad2 template to prime
Cdc20 for BubR1 binding. Dev Cell 16, 105-117.
Kwiatkowski, N., Jelluma, N., Filippakopoulos, P., Soundararajan, M., Manak, M.S.,
Kwon, M., Choi, H.G., Sim, T., Deveraux, Q.L., Rottmann, S., et al. (2010). Smallmolecule kinase inhibitors provide insight into Mps1 cell cycle function. Nat Chem
Biol 6, 359-368.
Lad, L., Lichtsteiner, S., Hartman, J.J., Wood, K.W., and Sakowicz, R. (2009). Kinetic
analysis of Mad2-Cdc20 formation: conformational changes in Mad2 are
catalyzed by a C-Mad2-ligand complex. Biochemistry 48, 9503-9515.
Lan, W., and Cleveland, D.W. (2010). A chemical tool box defines mitotic and interphase
roles for Mps1 kinase. J Cell Biol 190, 21-24.
Lau, D.T., and Murray, A.W. (2012). Mad2 and Mad3 cooperate to arrest budding yeast
in mitosis. Curr Biol 22, 180-190.
Lee, S.H., Sterling, H., Burlingame, A., and McCormick, F. (2008). Tpr directly binds to
Mad1 and Mad2 and is important for the Mad1-Mad2-mediated mitotic spindle
checkpoint. Genes Dev 22, 2926-2931.
Li, A., Saito, M., Chuang, J.Z., Tseng, Y.Y., Dedesma, C., Tomizawa, K., Kaitsuka, T., and
Sung, C.H. (2011). Ciliary transition zone activation of phosphorylated Tctex-1
controls ciliary resorption, S-phase entry and fate of neural progenitors. Nat Cell
Biol 13, 402-411.
Li, R., and Murray, A.W. (1991). Feedback control of mitosis in budding yeast. Cell 66,
519-531.
Li, Y., and Benezra, R. (1996). Identification of a human mitotic checkpoint gene:
hsMAD2. Science 274, 246-248.
137

Liu, D., Vader, G., Vromans, M.J., Lampson, M.A., and Lens, S.M. (2009). Sensing
chromosome bi-orientation by spatial separation of aurora B kinase from
kinetochore substrates. Science 323, 1350-1353.
Liu, D., Vleugel, M., Backer, C.B., Hori, T., Fukagawa, T., Cheeseman, I.M., and Lampson,
M.A. (2010). Regulated targeting of protein phosphatase 1 to the outer
kinetochore by KNL1 opposes Aurora B kinase. J Cell Biol 188, 809-820.
Luo, X., Tang, Z., Xia, G., Wassmann, K., Matsumoto, T., Rizo, J., and Yu, H. (2004). The
Mad2 spindle checkpoint protein has two distinct natively folded states. Nat
Struct Mol Biol 11, 338-345.
Luo, X., and Yu, H. (2008). Protein metamorphosis: the two-state behavior of Mad2.
Structure 16, 1616-1625.
Maciejowski, J., George, K.A., Terret, M.E., Zhang, C., Shokat, K.M., and Jallepalli, P.V.
(2010). Mps1 directs the assembly of Cdc20 inhibitory complexes during
interphase and mitosis to control M phase timing and spindle checkpoint
signaling. J Cell Biol 190, 89-100.
Maldonado, M., and Kapoor, T.M. (2011). Constitutive Mad1 targeting to kinetochores
uncouples checkpoint signaling from chromosome biorientation. Nat Cell Biol 13,
475-482.
Mansfeld, J., Collin, P., Collins, M.O., Choudhary, J.S., and Pines, J. (2011). APC15 drives
the turnover of MCC-CDC20 to make the spindle assembly checkpoint responsive
to kinetochore attachment. Nat Cell Biol 13, 1234-1243.
Mao, Y., Desai, A., and Cleveland, D.W. (2005). Microtubule capture by CENP-E silences
BubR1-dependent mitotic checkpoint signaling. J Cell Biol 170, 873-880.
Mapelli, M., Massimiliano, L., Santaguida, S., and Musacchio, A. (2007). The Mad2
conformational dimer: structure and implications for the spindle assembly
checkpoint. Cell 131, 730-743.
Martin-Lluesma, S., Stucke, V.M., and Nigg, E.A. (2002). Role of Hec1 in spindle
checkpoint signaling and kinetochore recruitment of Mad1/Mad2. Science 297,
2267-2270.
Meadows, J.C., Shepperd, L.A., Vanoosthuyse, V., Lancaster, T.C., Sochaj, A.M., Buttrick,
G.J., Hardwick, K.G., and Millar, J.B. (2011). Spindle checkpoint silencing requires
association of PP1 to both Spc7 and kinesin-8 motors. Dev Cell 20, 739-750.

138

Meraldi, P., Draviam, V.M., and Sorger, P.K. (2004a). Timing and checkpoints in the
regulation of mitotic progression. Dev Cell 7, 45-60.
Meraldi, P., Honda, R., and Nigg, E.A. (2004b). Aurora kinases link chromosome
segregation and cell division to cancer susceptibility. Curr Opin Genet Dev 14, 2936.
Merdes, A., Heald, R., Samejima, K., Earnshaw, W.C., and Cleveland, D.W. (2000).
Formation of spindle poles by dynein/dynactin-dependent transport of NuMA. J
Cell Biol 149, 851-862.
Merdes, A., Ramyar, K., Vechio, J.D., and Cleveland, D.W. (1996). A complex of NuMA
and cytoplasmic dynein is essential for mitotic spindle assembly. Cell 87, 447-458.
Mitchison, T., Evans, L., Schulze, E., and Kirschner, M. (1986). Sites of microtubule
assembly and disassembly in the mitotic spindle. Cell 45, 515-527.
Moore, J.K., Stuchell-Brereton, M.D., and Cooper, J.A. (2009). Function of dynein in
budding yeast: mitotic spindle positioning in a polarized cell. Cell Motil
Cytoskeleton 66, 546-555.
Morgan, D.O. (2008a). SnapShot: cell-cycle regulators I. Cell 135, 764-764 e761.
Morgan, D.O. (2008b). SnapShot: Cell-cycle regulators II. Cell 135, 974-974 e971.
Murray, A.W. (2011). A brief history of error. Nat Cell Biol 13, 1178-1182.
Musacchio, A. (2011). Spindle assembly checkpoint: the third decade. Philos Trans R Soc
Lond B Biol Sci 366, 3595-3604.
Musacchio, A., and Salmon, E.D. (2007). The spindle-assembly checkpoint in space and
time. Nat Rev Mol Cell Biol 8, 379-393.
Nilsson, J., Yekezare, M., Minshull, J., and Pines, J. (2008). The APC/C maintains the
spindle assembly checkpoint by targeting Cdc20 for destruction. Nat Cell Biol 10,
1411-1420.
Ogura, T., and Wilkinson, A.J. (2001). AAA+ superfamily ATPases: common structure-diverse function. Genes Cells 6, 575-597.
Oppermann, F.S., Grundner-Culemann, K., Kumar, C., Gruss, O.J., Jallepalli, P.V., and
Daub, H. (2012). Combination of chemical genetics and phosphoproteomics for
kinase signaling analysis enables confident identification of cellular downstream
targets. Mol Cell Proteomics 11, O111 012351.Palframan, W.J., Meehl, J.B.,
139

Jaspersen, S.L., Winey, M., and Murray, A.W. (2006). Anaphase inactivation of the
spindle checkpoint. Science 313, 680-684.
Pazour, G.J., Wilkerson, C.G., and Witman, G.B. (1998). A dynein light chain is essential
for the retrograde particle movement of intraflagellar transport (IFT). J Cell Biol
141, 979-992.
Petersen, J., and Hagan, I.M. (2003). S. pombe aurora kinase/survivin is required for
chromosome condensation and the spindle checkpoint attachment response.
Curr Biol 13, 590-597.
Petronczki, M., Lenart, P., and Peters, J.M. (2008). Polo on the Rise-from Mitotic Entry to
Cytokinesis with Plk1. Dev Cell 14, 646-659.
Pfau, S.J., and Amon, A. (2012). Chromosomal instability and aneuploidy in cancer: from
yeast to man. EMBO Rep 13, 515-527.
Pinsky, B.A., and Biggins, S. (2005). The spindle checkpoint: tension versus attachment.
Trends Cell Biol 15, 486-493.
Pinsky, B.A., Kung, C., Shokat, K.M., and Biggins, S. (2006). The Ipl1-Aurora protein
kinase activates the spindle checkpoint by creating unattached kinetochores. Nat
Cell Biol 8, 78-83.
Pinsky, B.A., Nelson, C.R., and Biggins, S. (2009). Protein phosphatase 1 regulates exit
from the spindle checkpoint in budding yeast. Curr Biol 19, 1182-1187.
Qiu, W., Derr, N.D., Goodman, B.S., Villa, E., Wu, D., Shih, W., and Reck-Peterson, S.L.
(2012). Dynein achieves processive motion using both stochastic and coordinated
stepping. Nat Struct Mol Biol 19, 193-200.
Reddy, S.K., Rape, M., Margansky, W.A., and Kirschner, M.W. (2007). Ubiquitination by
the anaphase-promoting complex drives spindle checkpoint inactivation. Nature
446, 921-925.
Rieder, C.L., Cole, R.W., Khodjakov, A., and Sluder, G. (1995). The checkpoint delaying
anaphase in response to chromosome monoorientation is mediated by an
inhibitory signal produced by unattached kinetochores. J Cell Biol 130, 941-948.
Rieder, C.L., Schultz, A., Cole, R., and Sluder, G. (1994). Anaphase onset in vertebrate
somatic cells is controlled by a checkpoint that monitors sister kinetochore
attachment to the spindle. J Cell Biol 127, 1301-1310.

140

Rosenberg, J.S., Cross, F.R., and Funabiki, H. (2011). KNL1/Spc105 recruits PP1 to silence
the spindle assembly checkpoint. Curr Biol 21, 942-947.
Santaguida, S., and Musacchio, A. (2009). The life and miracles of kinetochores. EMBO J
28, 2511-2531.
Santaguida, S., Tighe, A., D'Alise, A.M., Taylor, S.S., and Musacchio, A. (2010). Dissecting
the role of MPS1 in chromosome biorientation and the spindle checkpoint
through the small molecule inhibitor reversine. J Cell Biol 190, 73-87.
Santaguida, S., Vernieri, C., Villa, F., Ciliberto, A., and Musacchio, A. (2011). Evidence
that Aurora B is implicated in spindle checkpoint signaling independently of error
correction. EMBO J 30, 1508-1519.
Saurin, A.T., van der Waal, M.S., Medema, R.H., Lens, S.M., and Kops, G.J. (2011). Aurora
B potentiates Mps1 activation to ensure rapid checkpoint establishment at the
onset of mitosis. Nat Commun 2, 316.
Schmidt, H., Gleave, E.S., and Carter, A.P. (2012). Insights into dynein motor domain
function from a 3.3-A crystal structure. Nat Struct Mol Biol 19, 492-497.
Schroer, T.A. (2004). Dynactin. Annu Rev Cell Dev Biol 20, 759-779.
Shah, J.V., Botvinick, E., Bonday, Z., Furnari, F., Berns, M., and Cleveland, D.W. (2004).
Dynamics of centromere and kinetochore proteins; implications for checkpoint
signaling and silencing. Curr Biol 14, 942-952.
Shepperd, L.A., Meadows, J.C., Sochaj, A.M., Lancaster, T.C., Zou, J., Buttrick, G.J.,
Rappsilber, J., Hardwick, K.G., and Millar, J.B. (2012). Phosphodependent
Recruitment of Bub1 and Bub3 to Spc7/KNL1 by Mph1 Kinase Maintains the
Spindle Checkpoint. Curr Biol 22, 891-899.
Simonetta, M., Manzoni, R., Mosca, R., Mapelli, M., Massimiliano, L., Vink, M., Novak, B.,
Musacchio, A., and Ciliberto, A. (2009). The influence of catalysis on mad2
activation dynamics. PLoS Biol 7, e10.
Sironi L., Melixetian M., Faretta M., Prosperini E., Helin K., Musacchio A. (2001). Mad2
binding to Mad1 and Cdc20, rather than oligomerization, is required for spindle
checkpoint. Embo J 20, 6371-6382.
Sironi, L., Mapelli, M., Knapp, S., De Antoni, A., Jeang, K.T., and Musacchio, A. (2002).
Crystal structure of the tetrameric Mad1-Mad2 core complex: implications of a
'safety belt' binding mechanism for the spindle checkpoint. EMBO J 21, 24962506.
141

Soutoglou, E., Dorn, J.F., Sengupta, K., Jasin, M., Nussenzweig, A., Ried, T., Danuser, G.,
and Misteli, T. (2007). Positional stability of single double-strand breaks in
mammalian cells. Nat Cell Biol 9, 675-682.
Starr, D.A., Williams, B.C., Hays, T.S., and Goldberg, M.L. (1998). ZW10 helps recruit
dynactin and dynein to the kinetochore. J Cell Biol 142, 763-774.
Stehman, S.A., Chen, Y., McKenney, R.J., and Vallee, R.B. (2007). NudE and NudEL are
required for mitotic progression and are involved in dynein recruitment to
kinetochores. J Cell Biol 178, 583-594.
Sudakin, V., Chan, G.K., and Yen, T.J. (2001). Checkpoint inhibition of the APC/C in HeLa
cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol 154,
925-936.
Tang, Z., Bharadwaj, R., Li, B., and Yu, H. (2001). Mad2-Independent inhibition of
APCCdc20 by the mitotic checkpoint protein BubR1. Dev Cell 1, 227-237.
Tang, Z., Shu, H., Oncel, D., Chen, S., and Yu, H. (2004). Phosphorylation of Cdc20 by
Bub1 provides a catalytic mechanism for APC/C inhibition by the spindle
checkpoint. Mol Cell 16, 387-397.
Thompson, S.L., and Compton, D.A. (2010). Proliferation of aneuploid human cells is
limited by a p53-dependent mechanism. J Cell Biol 188, 369-381.
Vaisberg, E.A., Koonce, M.P., and McIntosh, J.R. (1993). Cytoplasmic dynein plays a role
in mammalian mitotic spindle formation. J Cell Biol 123, 849-858.
Vallee, R.B., McKenney, R.J., and Ori-McKenney, K.M. (2012). Multiple modes of
cytoplasmic dynein regulation. Nat Cell Biol 14, 224-230.
Vanoosthuyse, V., and Hardwick, K.G. (2009). A novel protein phosphatase 1-dependent
spindle checkpoint silencing mechanism. Curr Biol 19, 1176-1181.
Varetti, G., Guida, C., Santaguida, S., Chiroli, E., and Musacchio, A. (2011). Homeostatic
control of mitotic arrest. Mol Cell 44, 710-720.
Varma, D., Monzo, P., Stehman, S.A., and Vallee, R.B. (2008). Direct role of dynein motor
in stable kinetochore-microtubule attachment, orientation, and alignment. J Cell
Biol 182, 1045-1054.
Vink, M., Simonetta, M., Transidico, P., Ferrari, K., Mapelli, M., De Antoni, A.,
Massimiliano, L., Ciliberto, A., Faretta, M., Salmon, E.D., et al. (2006). In vitro FRAP

142

identifies the minimal requirements for Mad2 kinetochore dynamics. Curr Biol 16,
755-766.
Wadsworth, P., Lee, W.L., Murata, T., and Baskin, T.I. (2011). Variations on theme:
spindle assembly in diverse cells. Protoplasma 248, 439-446.
Wan, X., O'Quinn, R.P., Pierce, H.L., Joglekar, A.P., Gall, W.E., DeLuca, J.G., Carroll, C.W.,
Liu, S.T., Yen, T.J., McEwen, B.F., et al. (2009). Protein architecture of the human
kinetochore microtubule attachment site. Cell 137, 672-684.
Waters, J.C., Chen, R.H., Murray, A.W., and Salmon, E.D. (1998). Localization of Mad2 to
kinetochores depends on microtubule attachment, not tension. J Cell Biol 141,
1181-1191.
Weinert, T.A., Hartwell, L.H. (1988). The RAD9 gene controls the cell cycle response to
DNA damage in Saccharomyces cerevisiae. Science 241, 317-322.
Windecker, H., Langegger, M., Heinrich, S., and Hauf, S. (2009). Bub1 and Bub3 promote
the conversion from monopolar to bipolar chromosome attachment
independently of shugoshin. EMBO Rep 10, 1022-1028.
Xia, G., Luo, X., Habu, T., Rizo, J., Matsumoto, T., and Yu, H. (2004). Conformationspecific binding of p31(comet) antagonizes the function of Mad2 in the spindle
checkpoint. EMBO J 23, 3133-3143.
Yang, M., Li, B., Liu, C.J., Tomchick, D.R., Machius, M., Rizo, J., Yu, H., and Luo, X. (2008).
Insights into mad2 regulation in the spindle checkpoint revealed by the crystal
structure of the symmetric mad2 dimer. PLoS Biol 6, e50.
Yang, M., Li, B., Tomchick, D.R., Machius, M., Rizo, J., Yu, H., and Luo, X. (2007).
p31comet blocks Mad2 activation through structural mimicry. Cell 131, 744-755.
Yen, T.J., Compton, D.A., Wise, D., Zinkowski, R.P., Brinkley, B.R., Earnshaw, W.C., and
Cleveland, D.W. (1991). CENP-E, a novel human centromere-associated protein
required for progression from metaphase to anaphase. EMBO J 10, 1245-1254.
Young, A., Dictenberg, J.B., Purohit, A., Tuft, R., and Doxsey, S.J. (2000). Cytoplasmic
dynein-mediated assembly of pericentrin and gamma tubulin onto centrosomes.
Mol Biol Cell 11, 2047-2056.
Zich, J., Sochaj, A.M., Syred, H.M., Milne, L., Cook, A.G., Ohkura, H., Rappsilber, J., and
Hardwick, K.G. (2012). Kinase activity of fission yeast Mph1 is required for Mad2
and Mad3 to stably bind the anaphase promoting complex. Curr Biol 22, 296-301.

143

